EP1015556A1 - Stress-protected transgenic plants - Google Patents
Stress-protected transgenic plantsInfo
- Publication number
- EP1015556A1 EP1015556A1 EP97954562A EP97954562A EP1015556A1 EP 1015556 A1 EP1015556 A1 EP 1015556A1 EP 97954562 A EP97954562 A EP 97954562A EP 97954562 A EP97954562 A EP 97954562A EP 1015556 A1 EP1015556 A1 EP 1015556A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- gene
- plant
- transgenic plant
- expression
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000009261 transgenic effect Effects 0.000 title claims description 91
- 238000000034 method Methods 0.000 claims abstract description 58
- 230000006353 environmental stress Effects 0.000 claims abstract description 40
- 230000001965 increasing effect Effects 0.000 claims abstract description 27
- 108090000623 proteins and genes Proteins 0.000 claims description 112
- 230000014509 gene expression Effects 0.000 claims description 91
- 108020004414 DNA Proteins 0.000 claims description 40
- 230000035882 stress Effects 0.000 claims description 40
- 229920001184 polypeptide Polymers 0.000 claims description 37
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 37
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 37
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 13
- 102000004169 proteins and genes Human genes 0.000 claims description 12
- 230000018044 dehydration Effects 0.000 claims description 11
- 238000006297 dehydration reaction Methods 0.000 claims description 11
- 150000007523 nucleic acids Chemical group 0.000 claims description 8
- 230000001939 inductive effect Effects 0.000 claims description 6
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 5
- 108700026220 vif Genes Proteins 0.000 claims description 2
- 101000737786 Daucus carota Calcium-dependent protein kinase Proteins 0.000 claims 10
- 101000737787 Glycine max Calcium-dependent protein kinase SK5 Proteins 0.000 claims 10
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 101150042441 K gene Proteins 0.000 claims 1
- 241000196324 Embryophyta Species 0.000 description 227
- 210000004027 cell Anatomy 0.000 description 93
- 102000001253 Protein Kinase Human genes 0.000 description 82
- 108060006633 protein kinase Proteins 0.000 description 82
- 108010025267 calcium-dependent protein kinase Proteins 0.000 description 36
- 230000000694 effects Effects 0.000 description 22
- 210000001938 protoplast Anatomy 0.000 description 21
- JLIDBLDQVAYHNE-YKALOCIXSA-N (+)-Abscisic acid Chemical compound OC(=O)/C=C(/C)\C=C\[C@@]1(O)C(C)=CC(=O)CC1(C)C JLIDBLDQVAYHNE-YKALOCIXSA-N 0.000 description 20
- 108700019146 Transgenes Proteins 0.000 description 20
- 150000001413 amino acids Chemical group 0.000 description 18
- 230000001105 regulatory effect Effects 0.000 description 18
- 240000008042 Zea mays Species 0.000 description 15
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 15
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 15
- 235000009973 maize Nutrition 0.000 description 15
- 239000013604 expression vector Substances 0.000 description 14
- 238000003752 polymerase chain reaction Methods 0.000 description 14
- 230000019491 signal transduction Effects 0.000 description 14
- 239000005090 green fluorescent protein Substances 0.000 description 13
- 210000001519 tissue Anatomy 0.000 description 13
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 12
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 12
- 150000003839 salts Chemical class 0.000 description 12
- FCRACOPGPMPSHN-UHFFFAOYSA-N desoxyabscisic acid Natural products OC(=O)C=C(C)C=CC1C(C)=CC(=O)CC1(C)C FCRACOPGPMPSHN-UHFFFAOYSA-N 0.000 description 10
- 230000009466 transformation Effects 0.000 description 10
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 9
- 241000219194 Arabidopsis Species 0.000 description 9
- 235000001014 amino acid Nutrition 0.000 description 9
- 229940024606 amino acid Drugs 0.000 description 9
- 239000002299 complementary DNA Substances 0.000 description 9
- 229930027917 kanamycin Natural products 0.000 description 9
- 229960000318 kanamycin Drugs 0.000 description 9
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 9
- 229930182823 kanamycin A Natural products 0.000 description 9
- 235000018102 proteins Nutrition 0.000 description 9
- 230000006354 stress signaling Effects 0.000 description 9
- 239000013598 vector Substances 0.000 description 9
- 241000589158 Agrobacterium Species 0.000 description 8
- 101100235061 Hordeum vulgare HVA1 gene Proteins 0.000 description 8
- 230000001419 dependent effect Effects 0.000 description 8
- 239000013612 plasmid Substances 0.000 description 8
- 238000010561 standard procedure Methods 0.000 description 8
- 238000010367 cloning Methods 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 239000002773 nucleotide Substances 0.000 description 7
- 125000003729 nucleotide group Chemical group 0.000 description 7
- 230000004044 response Effects 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- 241000894007 species Species 0.000 description 7
- 238000011282 treatment Methods 0.000 description 7
- WCTAGTRAWPDFQO-UHFFFAOYSA-K trisodium;hydrogen carbonate;carbonate Chemical compound [Na+].[Na+].[Na+].OC([O-])=O.[O-]C([O-])=O WCTAGTRAWPDFQO-UHFFFAOYSA-K 0.000 description 7
- 241000701489 Cauliflower mosaic virus Species 0.000 description 6
- 108020004511 Recombinant DNA Proteins 0.000 description 6
- 239000011575 calcium Substances 0.000 description 6
- 108010060309 Glucuronidase Proteins 0.000 description 5
- 108700005075 Regulator Genes Proteins 0.000 description 5
- 240000003768 Solanum lycopersicum Species 0.000 description 5
- 238000003556 assay Methods 0.000 description 5
- 230000002363 herbicidal effect Effects 0.000 description 5
- 239000004009 herbicide Substances 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000003550 marker Substances 0.000 description 5
- 239000013615 primer Substances 0.000 description 5
- 230000003938 response to stress Effects 0.000 description 5
- 241000588724 Escherichia coli Species 0.000 description 4
- 102000053187 Glucuronidase Human genes 0.000 description 4
- 240000005979 Hordeum vulgare Species 0.000 description 4
- 235000007340 Hordeum vulgare Nutrition 0.000 description 4
- 241000209510 Liliopsida Species 0.000 description 4
- 108091034117 Oligonucleotide Proteins 0.000 description 4
- 108091000080 Phosphotransferase Proteins 0.000 description 4
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 4
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 4
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 244000038559 crop plants Species 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 108091006104 gene-regulatory proteins Proteins 0.000 description 4
- 102000034356 gene-regulatory proteins Human genes 0.000 description 4
- 238000001114 immunoprecipitation Methods 0.000 description 4
- 102000020233 phosphotransferase Human genes 0.000 description 4
- 238000004161 plant tissue culture Methods 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
- 238000013518 transcription Methods 0.000 description 4
- 230000035897 transcription Effects 0.000 description 4
- 230000005026 transcription initiation Effects 0.000 description 4
- 240000002791 Brassica napus Species 0.000 description 3
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 3
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 102000053602 DNA Human genes 0.000 description 3
- 101001055097 Homo sapiens Mitogen-activated protein kinase kinase kinase 6 Proteins 0.000 description 3
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 3
- 102100026889 Mitogen-activated protein kinase kinase kinase 6 Human genes 0.000 description 3
- 244000061176 Nicotiana tabacum Species 0.000 description 3
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 3
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 3
- 244000061456 Solanum tuberosum Species 0.000 description 3
- 235000002595 Solanum tuberosum Nutrition 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 238000004520 electroporation Methods 0.000 description 3
- 241001233957 eudicotyledons Species 0.000 description 3
- 238000009396 hybridization Methods 0.000 description 3
- 230000010354 integration Effects 0.000 description 3
- 230000003834 intracellular effect Effects 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 230000001404 mediated effect Effects 0.000 description 3
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 3
- 238000010369 molecular cloning Methods 0.000 description 3
- 230000035772 mutation Effects 0.000 description 3
- 108010058731 nopaline synthase Proteins 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 239000002751 oligonucleotide probe Substances 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 108091008146 restriction endonucleases Proteins 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 230000010474 transient expression Effects 0.000 description 3
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 3
- 229910052721 tungsten Inorganic materials 0.000 description 3
- 239000010937 tungsten Substances 0.000 description 3
- 238000011144 upstream manufacturing Methods 0.000 description 3
- JLIDBLDQVAYHNE-LXGGSRJLSA-N 2-cis-abscisic acid Chemical compound OC(=O)/C=C(/C)\C=C\C1(O)C(C)=CC(=O)CC1(C)C JLIDBLDQVAYHNE-LXGGSRJLSA-N 0.000 description 2
- 240000003291 Armoracia rusticana Species 0.000 description 2
- 235000011330 Armoracia rusticana Nutrition 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 108010006654 Bleomycin Proteins 0.000 description 2
- 235000011293 Brassica napus Nutrition 0.000 description 2
- 240000007124 Brassica oleracea Species 0.000 description 2
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 2
- 241000219193 Brassicaceae Species 0.000 description 2
- 102000000584 Calmodulin Human genes 0.000 description 2
- 108010041952 Calmodulin Proteins 0.000 description 2
- 108010035563 Chloramphenicol O-acetyltransferase Proteins 0.000 description 2
- 108091026890 Coding region Proteins 0.000 description 2
- 108020004635 Complementary DNA Proteins 0.000 description 2
- 241000195493 Cryptophyta Species 0.000 description 2
- 108010066133 D-octopine dehydrogenase Proteins 0.000 description 2
- 239000003155 DNA primer Substances 0.000 description 2
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 2
- 108700007698 Genetic Terminator Regions Proteins 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 101710154606 Hemagglutinin Proteins 0.000 description 2
- 206010020649 Hyperkeratosis Diseases 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- -1 Lane M Proteins 0.000 description 2
- 108060001084 Luciferase Proteins 0.000 description 2
- 239000005089 Luciferase Substances 0.000 description 2
- 101710093908 Outer capsid protein VP4 Proteins 0.000 description 2
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 2
- 108700001094 Plant Genes Proteins 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 101710176177 Protein A56 Proteins 0.000 description 2
- 102000006831 Protein phosphatase 2C Human genes 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
- 239000004473 Threonine Substances 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 244000098338 Triticum aestivum Species 0.000 description 2
- JUGOREOARAHOCO-UHFFFAOYSA-M acetylcholine chloride Chemical compound [Cl-].CC(=O)OCC[N+](C)(C)C JUGOREOARAHOCO-UHFFFAOYSA-M 0.000 description 2
- 238000001042 affinity chromatography Methods 0.000 description 2
- 238000012271 agricultural production Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 229960001561 bleomycin Drugs 0.000 description 2
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 239000013592 cell lysate Substances 0.000 description 2
- 230000003292 diminished effect Effects 0.000 description 2
- 239000012636 effector Substances 0.000 description 2
- 230000013020 embryo development Effects 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000010195 expression analysis Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 239000000185 hemagglutinin Substances 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 230000015784 hyperosmotic salinity response Effects 0.000 description 2
- 238000003119 immunoblot Methods 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000000243 photosynthetic effect Effects 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 230000008117 seed development Effects 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- 239000002438 stress hormone Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000003104 tissue culture media Substances 0.000 description 2
- 230000005030 transcription termination Effects 0.000 description 2
- 238000011426 transformation method Methods 0.000 description 2
- 238000013519 translation Methods 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 239000003981 vehicle Substances 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- ZBMRKNMTMPPMMK-UHFFFAOYSA-N 2-amino-4-[hydroxy(methyl)phosphoryl]butanoic acid;azane Chemical compound [NH4+].CP(O)(=O)CCC(N)C([O-])=O ZBMRKNMTMPPMMK-UHFFFAOYSA-N 0.000 description 1
- 241000589156 Agrobacterium rhizogenes Species 0.000 description 1
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 1
- 244000291564 Allium cepa Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 240000007087 Apium graveolens Species 0.000 description 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
- 235000010591 Appio Nutrition 0.000 description 1
- 108010037365 Arabidopsis Proteins Proteins 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 235000005340 Asparagus officinalis Nutrition 0.000 description 1
- 241000209763 Avena sativa Species 0.000 description 1
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 1
- 241000219198 Brassica Species 0.000 description 1
- 235000011303 Brassica alboglabra Nutrition 0.000 description 1
- 235000005637 Brassica campestris Nutrition 0.000 description 1
- 244000060924 Brassica campestris Species 0.000 description 1
- 235000003351 Brassica cretica Nutrition 0.000 description 1
- 235000011297 Brassica napobrassica Nutrition 0.000 description 1
- 244000178924 Brassica napobrassica Species 0.000 description 1
- 235000006008 Brassica napus var napus Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 235000012905 Brassica oleracea var viridis Nutrition 0.000 description 1
- 241000220240 Brassica oleracea var. alboglabra Species 0.000 description 1
- 244000304217 Brassica oleracea var. gongylodes Species 0.000 description 1
- 235000000540 Brassica rapa subsp rapa Nutrition 0.000 description 1
- 235000003343 Brassica rupestris Nutrition 0.000 description 1
- 101000741929 Caenorhabditis elegans Serine/threonine-protein phosphatase 2A catalytic subunit Proteins 0.000 description 1
- 108010003721 Calcium-Calmodulin-Dependent Protein Kinase Type 2 Proteins 0.000 description 1
- 241000701459 Caulimovirus Species 0.000 description 1
- 108091062157 Cis-regulatory element Proteins 0.000 description 1
- 241000218631 Coniferophyta Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 241000192700 Cyanobacteria Species 0.000 description 1
- IMXSCCDUAFEIOE-UHFFFAOYSA-N D-Octopin Natural products OC(=O)C(C)NC(C(O)=O)CCCN=C(N)N IMXSCCDUAFEIOE-UHFFFAOYSA-N 0.000 description 1
- IMXSCCDUAFEIOE-RITPCOANSA-N D-octopine Chemical group [O-]C(=O)[C@@H](C)[NH2+][C@H](C([O-])=O)CCCNC(N)=[NH2+] IMXSCCDUAFEIOE-RITPCOANSA-N 0.000 description 1
- 230000008836 DNA modification Effects 0.000 description 1
- 240000004585 Dactylis glomerata Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 241000219146 Gossypium Species 0.000 description 1
- HVLSXIKZNLPZJJ-TXZCQADKSA-N HA peptide Chemical compound C([C@@H](C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 HVLSXIKZNLPZJJ-TXZCQADKSA-N 0.000 description 1
- 101150067911 HVA1 gene Proteins 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- 101100396051 Hordeum vulgare HVA22 gene Proteins 0.000 description 1
- 108091092195 Intron Proteins 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 240000008415 Lactuca sativa Species 0.000 description 1
- 235000003228 Lactuca sativa Nutrition 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 101000763602 Manilkara zapota Thaumatin-like protein 1 Proteins 0.000 description 1
- 101000763586 Manilkara zapota Thaumatin-like protein 1a Proteins 0.000 description 1
- 241000219823 Medicago Species 0.000 description 1
- 240000004658 Medicago sativa Species 0.000 description 1
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 1
- 101000966653 Musa acuminata Glucan endo-1,3-beta-glucosidase Proteins 0.000 description 1
- 108010021466 Mutant Proteins Proteins 0.000 description 1
- 102000008300 Mutant Proteins Human genes 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 101000908196 Oryza sativa subsp. japonica Calcium-dependent protein kinase 23 Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 240000007377 Petunia x hybrida Species 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 108020005120 Plant DNA Proteins 0.000 description 1
- 108010064851 Plant Proteins Proteins 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 108010047313 Protein phosphatase 2C Proteins 0.000 description 1
- 230000006819 RNA synthesis Effects 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 108700008625 Reporter Genes Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- 244000082988 Secale cereale Species 0.000 description 1
- 235000002597 Solanum melongena Nutrition 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 101710151717 Stress-related protein Proteins 0.000 description 1
- 235000021536 Sugar beet Nutrition 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 101710195626 Transcriptional activator protein Proteins 0.000 description 1
- 108090000848 Ubiquitin Proteins 0.000 description 1
- 102000044159 Ubiquitin Human genes 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 241000219977 Vigna Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 108010055615 Zein Proteins 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 244000193174 agave Species 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 101150103518 bar gene Proteins 0.000 description 1
- 102000005936 beta-Galactosidase Human genes 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 210000003763 chloroplast Anatomy 0.000 description 1
- 230000004186 co-expression Effects 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000008260 defense mechanism Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000005059 dormancy Effects 0.000 description 1
- 235000005489 dwarf bean Nutrition 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000009313 farming Methods 0.000 description 1
- 244000037666 field crops Species 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 238000010359 gene isolation Methods 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 230000008570 general process Effects 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 235000004554 glutamine Nutrition 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 239000003721 gunpowder Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 238000003365 immunocytochemistry Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000007901 in situ hybridization Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000000099 in vitro assay Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- PGHMRUGBZOYCAA-UHFFFAOYSA-N ionomycin Natural products O1C(CC(O)C(C)C(O)C(C)C=CCC(C)CC(C)C(O)=CC(=O)C(C)CC(C)CC(CCC(O)=O)C)CCC1(C)C1OC(C)(C(C)O)CC1 PGHMRUGBZOYCAA-UHFFFAOYSA-N 0.000 description 1
- PGHMRUGBZOYCAA-ADZNBVRBSA-N ionomycin Chemical compound O1[C@H](C[C@H](O)[C@H](C)[C@H](O)[C@H](C)/C=C/C[C@@H](C)C[C@@H](C)C(/O)=C/C(=O)[C@@H](C)C[C@@H](C)C[C@@H](CCC(O)=O)C)CC[C@@]1(C)[C@@H]1O[C@](C)([C@@H](C)O)CC1 PGHMRUGBZOYCAA-ADZNBVRBSA-N 0.000 description 1
- 239000002555 ionophore Substances 0.000 description 1
- 230000000236 ionophoric effect Effects 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 238000011005 laboratory method Methods 0.000 description 1
- 230000011890 leaf development Effects 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000020429 meristem development Effects 0.000 description 1
- 230000000442 meristematic effect Effects 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 235000010460 mustard Nutrition 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 238000007899 nucleic acid hybridization Methods 0.000 description 1
- 230000031787 nutrient reservoir activity Effects 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 108010082527 phosphinothricin N-acetyltransferase Proteins 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 230000029553 photosynthesis Effects 0.000 description 1
- 238000010672 photosynthesis Methods 0.000 description 1
- 101150093033 pk gene Proteins 0.000 description 1
- 239000003375 plant hormone Substances 0.000 description 1
- 235000021118 plant-derived protein Nutrition 0.000 description 1
- 210000002706 plastid Anatomy 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 230000008488 polyadenylation Effects 0.000 description 1
- 230000004481 post-translational protein modification Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 210000001082 somatic cell Anatomy 0.000 description 1
- 238000009331 sowing Methods 0.000 description 1
- 229960000268 spectinomycin Drugs 0.000 description 1
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 1
- 238000003153 stable transfection Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000004114 suspension culture Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 238000003151 transfection method Methods 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
Definitions
- This invention relates to the fields of plant genetic engineering and crop protection.
- ABA abscisic acid
- environmental stress conditions such as drought, cold, and salinity
- ABA abscisic acid
- the accumulation of these gene products is thought to protect plants from stress induced damage.
- Many of these genes are also expressed at the late stage of embryogenesis during seed development and are thought to be important for seed desiccation and dormancy.
- Several studies have identified cis-acting elements and trans-acting factors important for the regulation of these stress-inducible genes. Background information relating to the aforementioned topics is found in the following references: Skriver and Mundy, Plant Cell 2:503, 1990; Bray, Plant Physiol.
- the invention features a method for protecting a plant against an environmental stress, the method including the steps of: (a) producing a transgenic plant cell including a recombinant protein kinase (PK) domain gene integrated into the genome of the transgenic plant cell and positioned for expression in the plant cell; and (b) growing a transgenic plant from the plant cell, wherein the PK domain gene is expressed in the transgenic plant.
- the method of the invention involves the expression of a PK domain gene which is capable of increasing the level of tolerance to an environmental stress, e.g., dehydration, salt, or temperature stress.
- the invention includes a PK domain gene which encodes a polypeptide that includes an amino acid sequence that is substantially identical to the amino acid sequence of ATCDPK1 or ATCDPKla.
- the invention includes a gene encoding a polypeptide having a PK domain that includes an amino acid sequence that is substantially identical to the amino acid sequence of ATCDPK1 or ATCDPKla.
- the invention features a method for protecting a plant against environmental stress, the method including the steps of: (a) producing a transgenic plant cell including a recombinant calcium-dependent protein kinase (CDPK) gene integrated into the genome of the transgenic plant cell and positioned for expression in the plant cell, the CDPK gene being capable of increasing the level of tolerance to an environmental stress, e.g., dehydration, salt, and temperature stresses; and (b) growing a transgenic plant from the plant cell, wherein the CDPK gene is expressed in the transgenic plant.
- a recombinant calcium-dependent protein kinase (CDPK) gene integrated into the genome of the transgenic plant cell and positioned for expression in the plant cell, the CDPK gene being capable of increasing the level of tolerance to an environmental stress, e.g., dehydration, salt, and temperature stresses.
- an environmental stress e.g., dehydration, salt, and temperature stresses
- the invention features a method for protecting a plant against environmental stress, the method including the steps of: (a) producing a transgenic plant cell including a recombinant calcium/calmodulin- dependent (CaM-K) gene integrated into the genome of the transgenic plant cell and positioned for expression in the plant cell; and (b) growing a transgenic plant from the plant cell wherein the CaM-K gene is expressed in the transgenic plant.
- the method of the invention includes the expression of a CaM-K gene (e.g., a mammalian CaM-KII gene) which is capable of increasing the level of tolerance to an environmental stress, e.g., against dehydration, salt, or temperature stress.
- a CaM-K gene e.g., a mammalian CaM-KII gene
- the invention features a method for protecting a plant against environmental stress, the method including the steps of: (a) producing a transgenic plant cell which includes a combination of at least two genes selected from the group consisting of a recombinant PK domain gene, a recombinant CDPK gene, and a CaM-K gene, each of the genes being integrated into the genome of the transgenic plant cell and positioned for expression in the plant cell; and (b) growing a transgenic plant from the plant cell, wherein each of the genes is expressed in the transgenic plant.
- the method of the invention includes the expression of genes which are capable of increasing the level of tolerance to an environmental stress, e.g., dehydration, salt, or temperature stress.
- the invention features a transgenic plant including a recombinant PK domain gene integrated into the genome of the transgenic plant and positioned for expression in the plant, the PK domain gene being capable of increasing the level of tolerance to an environmental stress, e.g., dehydration, salt, or temperature stress, on a transgenic plant expressing the recombinant PK domain.
- the invention features a transgenic plant including a recombinant CDPK gene integrated into the genome of the transgenic plant and positioned for expression in the plant, the recombinant CDPK gene being capable of increasing the level of tolerance to an environmental stress, e.g., dehydration, salt, or temperature stress, on a transgenic plant expressing the recombinant CDPK.
- the invention features a transgenic plant including a recombinant CaM-K gene integrated into the genome of the transgenic plant and positioned for expression in the plant, the recombinant CaM-K gene being capable of increasing the level of tolerance to an environmental stress, e.g., dehydration, salt, or temperature stress, on a transgenic plant which is expressing the recombinant CaM-K gene.
- an environmental stress e.g., dehydration, salt, or temperature stress
- the invention features a transgenic plant including a recombinant CDPK gene, PK domain gene, CaM-K gene, or any combination thereof integrated into the genome of the transgenic plant cell and positioned for expression in the plant cell, the CDPK, PK domain, and CaM-K genes being capable of increasing the level of tolerance to an environmental stress, e.g., dehydration, salt, or temperature stress, on a transgenic plant expressing the DNA.
- a recombinant CDPK gene, PK domain gene, CaM-K gene, or any combination thereof integrated into the genome of the transgenic plant cell and positioned for expression in the plant cell, the CDPK, PK domain, and CaM-K genes being capable of increasing the level of tolerance to an environmental stress, e.g., dehydration, salt, or temperature stress, on a transgenic plant expressing the DNA.
- an environmental stress e.g., dehydration, salt, or temperature stress
- the invention includes seeds and cells from any of the aforementioned transgenic plants.
- the invention features a substantially pure PK domain polypeptide capable of increasing the level of tolerance to an environmental stress, e.g., environmental stress in a transgenic plant.
- the invention features a PK domain polypeptide including an amino acid sequence substantially identical to the amino acid sequence shown in Fig. 5 (SEQ ID NO: 2).
- the invention features substantially pure DNA encoding a PK domain polypeptide capable of conferring tolerance to an environmental stress in a transgenic plant.
- This DNA may include a nucleic acid sequence substantially identical to the nucleic acid sequence shown in Fig. 5 (SEQ ID NO: 1).
- Such DNA may be operably linked to an expression control region for the expression of the PK polypeptide; and the expression control region may include a promoter (for example, a constitutive or inducible promoter).
- the invention features a cell (e.g., a plant cell) which includes the DNA of the invention.
- polypeptide is meant any chain of amino acids, regardless of length or post-translational modification (for example, glycosylation or phosphorylation).
- substantially identical is meant a polypeptide or nucleic acid exhibiting at least 70%, preferably 80%, more preferably 85%, and most preferably 90%, or even 95% sequence identity to a reference sequence.
- the length of comparison sequences will generally be at least 16 amino acids, preferably at least 20 amino acids, more preferably at least 25 amino acids, and most preferably 35 amino acids.
- the length of comparison sequences will generally be at least 50 nucleotides, preferably at least 60 nucleotides, more preferably at least 75 nucleotides, and most preferably 110 nucleotides.
- Sequence identity is typically measured using sequence analysis software (for example, Sequence Analysis Software Package of the Genetics Computer Group, University of Wisconsin Biotechnology Center, 1710 University Avenue, Madison, WI 53705, BLAST, FastA, or PILEUP/PRETTYBOX programs).
- sequence analysis software for example, Sequence Analysis Software Package of the Genetics Computer Group, University of Wisconsin Biotechnology Center, 1710 University Avenue, Madison, WI 53705, BLAST, FastA, or PILEUP/PRETTYBOX programs.
- Conservative substitutions typically include substitutions within the following groups: glycine alanine; valine, isoleucine, leucine; aspartic acid, glutamic acid, asparagine, glutamine; serine, threonine; lysine, arginine; and phenylalanine, tyrosine.
- a substantially pure polypeptide is meant a polypeptide (for example, the PK domain polypeptide shown in Fig. 5 (SEQ ID NO: 2)) that has been separated from components which naturally accompany it.
- the polypeptide is substantially pure when it is at least 60%, by weight, free from the proteins and naturally-occurring organic molecules with which it is naturally associated.
- the preparation is at least 75%, more preferably at least 90%, and most preferably at least 99%, by weight, a substantially pure polypeptide.
- a substantially pure PK domain polypeptide may be obtained, for example, by extraction from a natural source (for example, a plant cell); by expression of a recombinant nucleic acid encoding a PK domain polypeptide; or by chemically synthesizing the protein. Purity can be measured by any appropriate method, for example, column chromatography, polyacrylamide gel electrophoresis, or by HPLC analysis.
- derived from is meant isolated from or having the sequence of a naturally-occurring sequence (e.g., a cDNA, genomic DNA, synthetic DNA, or combination thereof).
- substantially pure DNA DNA that is free of the genes which, in the naturally-occurring genome of the organism from which the DNA of the invention is derived, flank the gene.
- the term therefore includes, for example, a recombinant DNA that is incorporated into a vector; into an autonomously replicating plasmid or virus; or into the genomic DNA of a prokaryote or eukaryote; or that exists as a separate molecule (for example, a cDNA or a genomic or cDNA fragment produced by PCR or restriction endonuclease digestion) independent of other sequences. It also includes a recombinant DNA which is part of a hybrid gene encoding additional polypeptide sequence.
- transformed cell is meant a cell into which (or into an ancestor of which) has been introduced, by means of recombinant DNA techniques, a DNA molecule encoding (as used herein) a regulator polypeptide (e.g., a CDPK, a PK domain, or a CaM-K polypeptide).
- a regulator polypeptide e.g., a CDPK, a PK domain, or a CaM-K polypeptide
- positioned for expression is meant that the DNA molecule is positioned adjacent to a DNA sequence which directs transcription and translation, if appropriate, of the sequence (i.e., facilitates the production of, for example, a CDPK polypeptide, a PK domain polypeptide, a CaM-K polypeptide, a recombinant protein, or an RNA molecule).
- reporter gene is meant a gene whose expression may be assayed; such genes include, without limitation, ⁇ -glucuronidase (GUS), luciferase, chloramphenicol transacetylase (CAT), green fluorescent protein (GFP), and ⁇ -galactosidase.
- expression control region is meant any minimal sequence sufficient to direct transcription.
- promoter elements that are sufficient to render promoter- dependent gene expression controllable for cell-, tissue-, or organ-specific gene expression, or elements that are inducible by external signals or agents (for example, light-, pathogen-, wound-, stress-, or hormone-inducible elements or chemical inducers such as SA or INA); such elements may be located in the 5' or 3' regions of the native gene or engineered into a transgene construct.
- operably linked is meant that a gene and a regulatory sequence(s) are connected in such a way as to permit gene expression when the appropriate molecules (for example, transcriptional activator proteins) are bound to the regulatory sequence(s).
- Plant cell is meant any self-propagating cell bounded by a semi- permeable membrane and containing a plastid. Such a cell also requires a cell wall if further propagation is desired.
- Plant cell includes, without limitation, algae, cyanobacteria, seeds, suspension cultures, embryos, meristematic regions, callus tissue, leaves, roots, shoots, gametophytes, sporophytes, pollen, and microspores.
- crucifer any plant that is classified within the Cruciferae family.
- the Cruciferae include many agricultural crops, including, without limitation, rape (for example, Brassica campestris and Brassica napus), broccoli, cabbage, Bmssel sprouts, radish, kale, Chinese kale, kohlrabi, cauliflower, turnip, rutabaga, mustard, horseradish, and Arabidopsis.
- transgene is meant any piece of DNA which is inserted by artifice into a cell, and becomes part of the genome of the organism which develops from that cell.
- Such a transgene may include a gene which is partly or entirely heterologous (i.e., foreign) to the transgenic organism, or may represent a gene homologous to an endogenous gene of the organism.
- transgenic any cell which includes a DNA sequence which is inserted by artifice into a cell and becomes part of the genome of the organism which develops from that cell.
- the transgenic organisms are generally transgenic plants and the DNA (transgene) is inserted by artifice into the nuclear or plastidic genome.
- the level of tolerance in a transgenic plant of the invention is at least 5%, 10%, or 20% (and preferably 30% or 40%) greater than the tolerance to an environmental stress exhibited in a control plant.
- the level of tolerance to an environmental stress is 50% greater, 60% greater, and more preferably even 75% or 90% greater than a control plant; with up to 100% above the level of tolerance as compared to a control plant being most preferred.
- the level of tolerance is measured using conventional methods.
- the level of stress tolerance to salinity may be determined by comparing physical features and characteristics (for example, plant height and weight) of transgenic plants and control plants.
- the invention provides a number of important advances and advantages for the protection of plants against environmental stress, such as drought, salt, and temperature.
- the invention facilitates an effective and economical means to improve agronomically important traits of plants for tolerating the effects of dehydration, salinity, cold, and heat.
- the invention provides for increased production efficiency, as well as for improvements in quality and yield of crop plants and ornamentals.
- the invention contributes to the production of high quality and high yield agricultural products: for example, fruits, ornamentals, vegetables, cereals, and field crops.
- the invention further provides a means for mediating the expression of stress- related protective proteins that enable a plant to tolerate the effects of environmental stress.
- transgenic plants constitutively producing a recombinant CDPK gene product, a PK domain, or CaM-K are capable of turning on a plant's stress signal transduction pathway by allowing the expression of multiple stress-related proteins, which in turn enhances the plant's tolerance to multiple stress conditions. Expression of these gene products therefore obviates the need to express individual stress-related genes as a means to promote plant defense mechanisms against adverse conditions.
- FIG. 1 shows a series of photographs demonstrating stress signaling in maize leaf protoplasts as visualized by green-fluorescent (GFP) expression.
- GFP green-fluorescent
- Fig. 2 shows a series of photographs demonstrating that intracellular Ca 2+ elevation activates stress signaling.
- Fig. 3 A shows a schematic illustration of the structural comparison between plant CDPKs and mammalian CaMKII.
- Fig. 3B shows the sequence comparison among the kinase domains of four ATCDPKs. Identical amino acids are highlighted.
- Fig. 3C shows the schematic illustrations of various PK constructs.
- Fig. 3D shows a photograph of a gel illustrating the immunoprecipitation of eight PKs with anti-HA.
- Fig. 3E shows a graph demonstrating that ATCDPK1 and ATCDPKla activate stress-inducible transcription.
- Fig. 4A shows a photograph of a gel illustrating the immunoprecipitation of ATCDPK1 and ATCDPK1(K40M) mutant proteins.
- Fig. 4B shows a series of photographs demonstrating that the ATCDPK1 (K40M) mutant does not activate stress signaling.
- Fig. 4C shows a graph demonstrating that PP2C blocks the action of
- Fig. 4D shows a schematic illustration of a model for stress signal transduction in plant cells.
- Fig. 5 shows the nucleotide and amino acid sequences of the ATCDPKla PK domain, SEQ ID NO: 1 and SEQ ID NO: 2, respectively.
- CDPKl and CDPKl a are closely related Ca 2+ dependent protein kinases that activate a stress-inducible promoter, bypassing stress signals.
- the effects of CDPKl and CDPKl a are specific since six distinct plant protein kinases, including two other CDPKs, failed to mimic stress signaling. The activation is abolished by a CDPKl mutation in the kinase domain, and diminished by a constitutively active protein phosphatase 2C capable of blocking the stress hormone ABA responses.
- CDPKs including their PK domains
- CDPKl and CDPKl a are therefore examples of positive regulators for controlling stress signal transduction in plants. Expression of such regulators in transgenic plants is useful for turning on the stress signal transduction pathway as a means for increasing plant tolerance to multiple stress conditions, including drought, salinity, and extreme temperature conditions.
- GFP green- fluorescent protein
- the barley HVA1 promoter was obtained by PCR using barley genomic DNA and two primers: 5TCCACCGAGATGCCGACGCA-3' (SEQ ID NO: 17) and 5'-GTTGGAGGCCATGGTCGTCTCACGAT-3' (SEQ ID NO: 18).
- the CDPK HVA1 promoter and the SGFP were fused at the ATG Ncol site.
- the CDPK HVA1 gene has been reported to be activated by multiple stress signals in vegetative tissues (Straub et al., Plant Mol. Biol. 26:617, 1994). Four clones were selected and tested for stress responses with identical results as is discussed below.
- Maize leaf protoplasts were electroporated with the plasmid DNA carrying HVA1-SGFP and divided (10 5 cells/ml per sample) for various treatments: constant light (15 ⁇ Em "2 S " ') at 23 °C for sixteen hours (Control), 0°C for four hours followed by twelve hours at 23 °C (Cold), 0.2 M NaCl for three hours, washed, and incubated for thirteen hours (Salt), constant darkness for sixteen hours (Dark), and 100 ⁇ M ABA for sixteen hours (ABA) (Fig. 1).
- the protocol for transient expression analysis using maize leaf protoplasts has been described by Sheen (EMBO J. 12: 3497, 1993) and Chiu et al. (Curr. Biol. 6:225, 1996).
- HVA1-SGFP into maize leaf protoplasts
- the expression of GFP was found to be enhanced by cold, high salt, dark, and ABA (Fig. 1).
- These responses were specific to HVA1-SGFP because the expression of an internal control, generated by fusing the maize ubiquitin promoter (Christensen et al., Plant Mol. Biol. 18:675, 1992) and the ⁇ -glucuronidase gene (UBI-GUS) (Jefferson, Plant Mol. Biol. Rep. 5:387, 1987), was not affected (data not shown).
- the GFP expression derived from UBI-SGFP was not changed by the same treatments (data not shown).
- SGFP (UBI) were treated with 1 mM Ca 2+ , 1 mM Ca 2 7l 00 nM A23187, and 1 mM Ca 2+ /100 nM ionomycin, respectively designated "C,” "A,” and “I” in Fig.
- UBI-SGFP was constructed by inserting the UBI promoter from pAHC27
- Ca 2 7calmodulin-dependent KPII Ca 2 7calmodulin-dependent KPII (CaMKII) (Kapiloff et al, Proc. Natl. Acad. Sci. USA 88:3710, 1991).
- this family of PKs carries a calmodulin-like domain at the C-terminus (Fig. 3A). This unique feature presumably allows CDPKs to respond to Ca 2+ signals directly without calmodulin.
- Various other domains found in CaMKII and CDPK are shown in Fig. 3A, these include: (H) hinge, (N) NH 2 . terminal domain for some CDPKs (J) junction, (EF) EF-hand Ca 2+ -binding site (Harper et al.
- CDPKs are the most prevalent serine/threonine PKs found in higher plants as the cloning of numerous CDPKs in a broad range of plant species has been reported (Harper et al. Science 252:951, 1991 ; Suen and Choi, Plant Mol. Biol. 17:581 , 1991; Roberts and Harmon, Ann. Rev. Plant Physiol. Plant Mol. Biol. 43:375, 1992; Estruch et al, Proc. Natl. Acad. Sci. USA 91 :8837, 1994; Urao et al. Plant Physiol. 105: 1461, 1994; Urao et al, Mol. Gen. Genet. 244:331, 1994; Harper et al, Biochem.
- AKl/ATCDPK and ATCDPKla Two CDPKs (ATCDPKl and ATCDPKla) are closely related (96% amino acid and similarity) while the other two CDPKs (AKl/ATCDPK and ATCDPK2 have more divergent sequences (78% and 75% amino acid similarity respectively, to ATCDPKl) (Fig. 3B).
- AKl/ATCDPK and ATCDPK2 possess calcium-dependent PK activity and the truncated AKl/ATCDPK has calcium-independent (constitutively active) PK activity by (Urao et al, Mol. Gen. Genet. 244:331 , 1994; and Harper et al, Bioch. 33:7267, 1994).
- ATCDPKla The PK activity of ATCDPKl, however, has not been demonstrated in vitro because it does not phosphorylate common PK substrates (Urao et al, Mol. Gen. Genet. 244:331, 1994).
- the ATCDPKla cDNA that has restriction enzyme digestion patterns distinct from those of ATCDPKl , was identified during the isolation of ATCDPKl by polymerase chain reaction (PCR) (Minet et al. Plant J. 2:417,1992).
- PCR polymerase chain reaction
- the nucleotide and amino acid sequences of the ATCDPKla PK are shown in Fig. 5 (SEQ ID NO: 1 and 2, respectively).
- GCGGATCCATGGAGACGAAGCCAAACCCTA-3' (SEQ ID NO: 7) and 5*- GTCAAGGCCTTGCTTGTTCATCGACAATCC-3' (SEQ ID NO: 8 ); (ATPKa) 5'-CATGCCATGGCTCCGGCGACTAATTCACCG-3' (SEQ ID NO: 9) and
- Truncated forms containing all eleven PK domains analogous to the construction of a constitutively active mutant of CaMKII in mammals (Kapiloff et al, Proc. Natl. Acad. Sci. 88, 7267, 1994) (Fig. 3 A and Fig. 3B), were inserted into the plant expression vector with a strong constitutive promoter 35SC4PPDK (Sheen, EMBO J 12:3497, 1993; Chiu et al. Curr. Biol. 6:225,1996). The putative regulatory domains of theses PKs were deleted (Fig. 3C).
- PKs were fused in frame to a double hemagglutinin (HA) epitope tag (designated DHA in Fig. 3C) at the C-terminus and inserted into a plant expression vector (Sheen, EMBO J. 12:3497, 1993; and Chiu et al, Curr. Biol. 6:225, 1996).
- HA hemagglutinin
- PKs in transfected maize leaf protoplasts were demonstrated by immunoprecipitation of [ 35 S] methionine labeled proteins with the anti-HA monoclonal antibody (Fig. 3D).
- Transfected protoplasts were incubated for four hours to allow mRNA accumulation and then labeled with 200 ⁇ Ci/ml of [ 35 S] methionine for twelve hours before harvest.
- Immunoprecipitation was carried out based on a published protocol by Kapiloff et al. (Proc. Natl. Acad. Sci. USA 88:3710, 1991). The proteins were separated on a 12.5% SDS-PAGE gel and visualized by fluorography.
- HVA1-LUC luciferase coding sequence
- Maize leaf protoplasts were transfected with HVA 1 -LUC alone and incubated without (Fig. 3E, "C") or with 100 ⁇ M ABA (Fig. 3E, "A”). HVA1- LUC was also co-electroporated with the PK constructs (1-8) shown in Fig. 3C and Fig. 3D, and incubated without ABA (Fig. 3E, "1-8"). Relative LUC activities from duplicated samples are shown. About 2% of the cell lysates were used for LUC (Luehrsen et al, Meth. Enz. 216:397, 1992) and GUS assays (Sheen, EMBO J. 12:3497, 1993; and Jefferson, Plant Mol. Biol.
- CDPKl Activates but PP2C Abolishes Stress Signaling
- PK activity is important for the activation of the stress- inducible HVA1 promoter
- a null mutation was made by site-directed mutagenesis to eliminate the ATP binding site (K40) in ATCDPKl (Urao et al, Mol. Gen. Genet. 244:331 , 1994; and Kapiloff et al, Proc. Natl. Acad. Sci. USA 88:3710, 1991) and analyzed as follows. Maize leaf protoplasts were electroporated with HVA1-SGFP alone, or with ATCDPKl (CDPKl) and the ATCDPKl (K40M) mutant (CDPKlmut). About 10 5 protoplasts from each treatment were observed using a fluorescence microscope (Chiu et al, Curr.
- the kinase mutation did not affect the expression of the protein (Fig. 4A), but it could no longer activate the expression of HVA1-GFP (Fig. 4B).
- the expression of UBI-SGFP was not affected by ATCDPKl or the ATCDPKl mutant (data not shown). This result indicates that the PK domain of ATCDPKl was required and sufficient to recognize specific protein substances mediating stress signal transduction.
- the deleted regulatory domain was likely involved in PK activity control in response to stress signals (Harper et al. Science 252:951, 1991 ; Suen and Choi, Plant Mol. Biol. 17:581, 1991 ; Roberts and Harmon, Ann. Rev. Plant Physiol. Plant Mol. Biol.
- ATCDPKl and ATCDPKl a are positive regulators in plant stress signal transduction
- a specific and constitutively active Arabidopsis protein phosphatase 2C (PP2C) capable of abolishing ABA responses was examined as follows. Maize leaf protoplasts were electroporated with HVA 1 -LUC alone or with the effectors as indicated. PP2C null did not show PP2C activity (data not shown).
- the CDPK sequences described herein may be used, together with conventional screening methods of nucleic acid hybridization screening.
- hybridization techniques and screening procedures are well known to those skilled in the art and are described, for example, in Benton and Davis, Science 196: 180, 1977; Grunstein and Hogness, Proc. Natl. Acad. Sci, USA 72:3961, 1975; Ausubel et al. Current Protocols in Molecular Biology, Wiley Interscience, New York, and Berger and Kimmel, Guide to Molecular Cloning Techniques, 1987, Academic Press, New York.;; and Sambrook et al. Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, New York.
- all or part of the CDPK may be used as a probe to screen a recombinant plant DNA library for genes having sequence identity to the CDPK gene or the PK domain.
- Hybridizing sequences are detected by plaque or colony hybridization according to the methods described below.
- using all or a portion of the amino acid sequence of the CDPK may be used as a probe to screen a recombinant plant DNA library for genes having sequence identity to the CDPK gene or the PK domain.
- PK polypeptide SEQ ID NO: 2
- PK degenerate oligonucleotide probes i.e., a mixture of all possible coding sequences for a given amino acid sequence.
- oligonucleotides may be based upon the sequence of either DNA strand and any appropriate portion of the PK sequence.
- General methods for designing and preparing such probes are provided, for example, in Ausubel et al, 1996, Current Protocols in Molecular Biology, Wiley Interscience, New York, and Berger and Kimmel, Guide to Molecular Cloning Techniques, 1987, Academic Press, New York.
- oligonucleotides are useful for PK gene isolation, either through their use as probes capable of hybridizing to PK complementary sequences or as primers for various amplification techniques, for example, polymerase chain reaction (PCR) cloning strategies.
- PCR polymerase chain reaction
- a combination of different oligonucleotide probes may be used for the screening of a recombinant DNA library.
- the oligonucleotides may be detectably- labeled using methods known in the art and used to probe filter replicas from a recombinant DNA library.
- Recombinant DNA libraries are prepared according to methods well known in the art, for example, as described in Ausubel et al. (supra), or they may be obtained from commercial sources.
- PK oligonucleotides may also be used as primers in amplification cloning strategies, for example, using PCR.
- PCR methods are well known in the art and are described, for example, in PCR Technology, Erlich, ed, Stockton Press, London, 1989; PCR Protocols: A Guide to Methods and Applications, Innis et al, eds. Academic Press, Inc., New York, 1990; and Ausubel et al. (supra).
- Primers are optionally designed to allow cloning of the amplified product into a suitable vector, for example, by including appropriate restriction sites at the 5' and 3' ends of the amplified fragment (as described herein).
- PK sequences may be isolated using the PCR "RACE” technique, or Rapid Amplification of cDNA Ends (see, e.g., Innis et al. (supra)).
- RACE Rapid Amplification of cDNA Ends
- oligonucleotide primers based on an PK sequence are oriented in the 3' and 5' directions and are used to generate overlapping PCR fragments. These overlapping 3'- and 5 '-end RACE products are combined to produce an intact full-length cDNA. This method is described in Innis et al. (supra); and Frohman et al, Proc. Natl. Acad. Sci. USA 85:8998, 1988.
- Confirmation of a sequence's relatedness to the PK polypeptide family may be accomplished by a variety of conventional methods including, but not limited to, sequence comparison of the gene and its expressed product.
- sequence comparison of the gene and its expressed product may be accomplished by a variety of conventional methods including, but not limited to, sequence comparison of the gene and its expressed product.
- activity of the gene product may be evaluated according to any of the techniques described.
- a regulator of the stress response e.g., CDPK, PK, or CaM-K sequences
- CDPK e.g., CDPK, PK, or CaM-K sequences
- the regulators of the invention may be produced in a prokaryotic host, for example, E.
- coli or in a eukaryotic host, for example, Saccharomyces cerevisiae, mammalian cells (for example, COS 1 or NIH 3T3 cells), or any of a number of plant hosts including, without limitation, algae, tree species, ornamental species, temperate fruit species, tropical fruit species, vegetable species, legume species, crucifer species, monocots, dicots, or in any plant of commercial or agricultural significance.
- a eukaryotic host for example, Saccharomyces cerevisiae, mammalian cells (for example, COS 1 or NIH 3T3 cells), or any of a number of plant hosts including, without limitation, algae, tree species, ornamental species, temperate fruit species, tropical fruit species, vegetable species, legume species, crucifer species, monocots, dicots, or in any plant of commercial or agricultural significance.
- suitable plant hosts include, but are not limited to, Conifers, Petunia, Tomato, Potato, Tobacco, Arabidopsis, Lettuce, Sunflower, Oilseed rape, Flax, Cotton, Sugarbeet, Celery, Soybean, Alfalfa, Medicago, Lotus, Vigna, Cucumber, Carrot, Eggplant, Cauliflower, Horseradish, Morning Glory, Poplar, Walnut, Apple, Grape, Asparagus, Rice, Maize, Millet, Onion, Barley, Orchard grass, Oat, Rye, and Wheat.
- expression constructs may be expressed in a transgenic plant to turn on the stress signal transduction pathway to enhance plant tolerance to multiple stress conditions.
- the method of transformation or transfection and the choice of vehicle for expression of the regulator polypeptide will depend on the host system selected. Transformation and transfection methods are described, e.g., in Ausubel et al. (supra); Weissbach and Weissbach, Methods for Plant Molecular Biology, Academic Press, 1989; Gelvin et al. Plant Molecular Biology Manual, Kluwer Academic Publishers, 1990; Kindle, K, Proc. Natl. Acad. Sci, U.S.A 87:1228, 1990; Potrykus, I, Annu. Rev. Plant Physiol. Plant Mol.
- Expression vehicles may be chosen from those provided, e.g., in Cloning Vectors: A Laboratory Manual (P.H. Pouwels et al, 1985, Supp. 1987); Gasser and Fraley (supra); Clontech Molecular Biology Catalog (Catalog 1992/93 Tools for the Molecular Biologist, Palo Alto, CA); and the references cited above.
- Other expression constructs are described by Fraley et al. (U.S. Pat. No. 5,352,605).
- a regulator polypeptide e.g. CDPK, PK domain, or
- CaM-K is produced by a stably-transfected plant cell line, a transiently- transfected plant cell line, or by a transgenic plant.
- a number of vectors suitable for stable transfection of plant cells or for the establishment of transgenic plants are available to the public; such vectors are described in Pouwels et al. (supra), Weissbach and Weissbach (supra), and Gelvin et al. (supra). Methods for constructing such cell lines are described in, e.g., Weissbach and Weissbach (supra), and Gelvin et al. (supra).
- plant expression vectors include (1) a cloned plant gene under the transcriptional control of 5' and 3' regulatory sequences and (2) a dominant selectable marker.
- plant expression vectors may also contain, if desired, a promoter regulatory region (for example, one conferring inducible or constitutive, pathogen- or wound-induced, environmentally- or developmentally-regulated, or cell- or tissue-specific expression), a transcription initiation start site, a ribosome binding site, an RNA processing signal, a transcription termination site, and/or a polyadenylation signal.
- nucleic acid sequence encoding a regulator polypeptide e.g., CDPK, PK, or CaM-K sequence
- a regulator polypeptide e.g., CDPK, PK, or CaM-K sequence
- the flanking regions may be subjected to mutagenesis.
- the regulator DNA sequence of the invention may, if desired, be combined with other DNA sequences in a variety of ways.
- the regulator DNA sequence of the invention may be employed with all or part of the gene sequences normally associated with itself.
- a DNA sequence encoding a regulator polypeptide e.g., a CDPK, a PK domain, or a CaM-K
- a DNA construct having a transcription initiation control region capable of promoting transcription and translation in a host cell is combined in a DNA construct having a transcription initiation control region capable of promoting transcription and translation in a host cell.
- the constructs will involve regulatory regions functional in plants which provide for modified production of the regulator protein as discussed herein.
- the open reading frame coding for the regulator protein or functional fragment thereof will be joined at its 5' end to a transcription initiation regulatory region such as the sequence naturally found in the 5' upstream region of the regulator structural gene (e.g., CDPK, PK domain, or CaM-K). Numerous other transcription initiation regions are available which provide for constitutive or inducible regulation.
- appropriate 5' upstream non-coding regions are obtained from other genes, for example, from genes regulated during meristem development, seed development, embryo development, or leaf development.
- Transcript termination regions may be provided by the DNA sequence encoding the regulator protein (e.g., CDPK, PK domain, or CaM-K) or any convenient transcription termination region derived from a different gene source.
- the transcript termination region will contain preferably at least 1-3 kb of sequence 3' to the structural gene from which the termination region is derived.
- Plant expression constructs having, for example, CDPK as the DNA sequence of interest for expression may be employed with a wide variety of plant life. Such genetically-engineered plants are useful for a variety of industrial and agricultural applications as discussed herein.
- a useful plant promoter is a caulimovirus promoter, for example, a cauliflower mosaic virus (CaMV) promoter.
- CaMV cauliflower mosaic virus
- These promoters confer high levels of expression in most plant tissues, and the activity of these promoters is not dependent on virally encoded proteins.
- CaMV is a source for both the 35S and 19S promoters. In most tissues of transgenic plants, the CaMV 35S promoter is a strong promoter (see, e.g., Odell et al. Nature 313:810, 1985).
- the CaMV promoter is also highly active in monocots (see, e.g., Dekeyser et al. Plant Cell 2:591, 1990; Terada and Shimamoto, Mol. Gen. Genet. 220:389, 1990). Moreover, activity of this promoter can be further increased (i.e., between 2-10 fold) by duplication of the CaMV 35S promoter (see e.g., Kay et al. Science 236: 1299, 1987; Ow et al, Proc. Natl. Acad. Sci., U.S.A. 84:4870, 1987; and Fang et al. Plant Cell 1 : 141 , 1989).
- the regulator gene product e.g., CDPK, PK domain, or CaM-K
- the regulator gene product e.g., CDPK, PK domain, or CaM-K
- gene promoters each with its own distinct characteristics embodied in its regulatory sequences, shown to be regulated in response to the environment, hormones, and/or developmental cues. These include gene promoters that are responsible for heat-regulated gene expression (see, e.g., Callis et al. Plant Physiol. 88:965, 1988; Takahashi and Komeda, Mol. Gen. Genet. 219:365, 1989; and Takahashi et al, Plant J.
- light-regulated gene expression e.g., the pea rbcS-3A described by Kuhlemeier et al. Plant Cell 1 :471 , 1989; the maize rbcS promoter described by Schaffner and Sheen, Plant Cell 3:997, 1991 ; or the cholorphyll a/b-binding protein gene found in pea described by Simpson et al, EMBO J. 4:2723, 1985
- hormone- regulated gene expression for example, the abscisic acid (ABA) responsive sequences from the Em gene of wheat described by Marcotte et al.
- Plant expression vectors may also optionally include RNA processing signals, e.g, introns, which have been shown to be important for efficient RNA synthesis and accumulation (Callis et al. Genes and Dev. 1 : 1183, 1987).
- RNA processing signals e.g, introns
- the location of the RNA splice sequences can dramatically influence the level of transgene expression in plants.
- an intron may be positioned upstream or downstream of a CDPK, Cam-K, or PK domain polypeptide-encoding sequence in the transgene to modulate levels of gene expression.
- the expression vectors may also include regulatory control regions which are generally present in the 3' regions of plant genes (Thomburg et al, Proc. Natl. Acad.
- the 3' terminator region may be included in the expression vector to increase stability of the mRNA.
- One such terminator region may be derived from the PI-II te ⁇ ninator region of potato.
- other commonly used terminators are derived from the octopine or nopaline synthase signals.
- the plant expression vector also typically contains a dominant selectable marker gene used to identify those cells that have become transformed.
- Useful selectable genes for plant systems include genes encoding antibiotic resistance genes, for example, those encoding resistance to hygromycin, kanamycin, bleomycin, G418, streptomycin, or spectinomycin. Genes required for photosynthesis may also be used as selectable markers in photosynthetic-deficient strains. Finally, genes encoding herbicide resistance may be used as selectable markers; useful herbicide resistance genes include the bar gene encoding the enzyme phosphinothricin acetyltransferase and conferring resistance to the broad spectrum herbicide Basta® (Hoechst AG, Frankfurt, Germany).
- Efficient use of selectable markers is facilitated by a determination of the susceptibility of a plant cell to a particular selectable agent and a determination of the concentration of this agent which effectively kills most, if not all, of the transformed cells.
- Some useful concentrations of antibiotics for tobacco transformation include, e.g., 75-100 ⁇ g/mL (kanamycin), 20-50 ⁇ g/mL (hygromycin), or 5-10 ⁇ g/mL (bleomycin).
- a useful strategy for selection of transformants for herbicide resistance is described, e.g., by Vasil et al, supra.
- Plant Transformation Upon construction of the plant expression vector, several standard methods are available for introduction of the vector into a plant host, thereby generating a transgenic plant. These methods include (1) Agrobacterium- mediated transformation (A. tumefaciens or A. rhizogenes) (see, e.g., Lichtenstein and Fuller, In: Genetic Engineering, vol 6, PWJ Rigby, ed, London, Academic Press, 1987; and Lichtenstein, C.P, and Draper, J,. In: DNA Cloning, Vol II, D.M. Glover, ed, Oxford, IRI Press, 1985)), (2) the particle delivery system (see, e.g., Gordon-Kamm et al.
- Agrobacterium- mediated transformation A. tumefaciens or A. rhizogenes
- Lichtenstein and Fuller In: Genetic Engineering, vol 6, PWJ Rigby, ed, London, Academic Press, 1987; and Lichtenstein, C.P, and Dra
- the general process for manipulating genes to be transferred into the genome of plant cells is carried out in two phases.
- the plasmid contains an origin of replication that allows it to replicate in Agrobacterium and a high copy number origin of replication functional in E. coli. This permits facile production and testing of transgenes in E. coli prior to transfer to Agrobacterium for subsequent introduction into plants.
- Resistance genes can be carried on the vector, one for selection in bacteria, for example, streptomycin, and another that will function in plants, for example, a gene encoding kanamycin resistance or herbicide resistance. Also present on the vector are restriction endonuclease sites for the addition of one or more transgenes and directional T-DNA border sequences which, when recognized by the transfer functions of Agrobacterium, delimit the DNA region that will be transferred to the plant.
- plant cells may be transformed by shooting into the cell tungsten microprojectiles on which cloned DNA is precipitated.
- a gunpowder charge 22 caliber Power Piston Tool Charge
- an air-driven blast drives a plastic macroprojectile through a gun barrel.
- An aliquot of a suspension of tungsten particles on which DNA has been precipitated is placed on the front of the plastic macroprojectile.
- the latter is fired at an acrylic stopping plate that has a hole through it that is too small for the macroprojectile to pass through.
- the plastic macroprojectile smashes against the stopping plate, and the tungsten microprojectiles continue toward their target through the hole in the plate.
- the target can be any plant cell, tissue, seed, or embryo.
- the DNA introduced into the cell on the microprojectiles becomes integrated into either the nucleus or the chloroplast.
- Plant cells transformed with a plant expression vector can be regenerated, for example, from single cells, callus tissue, or leaf discs according to standard plant tissue culture techniques. It is well known in the art that various cells, tissues, and organs from almost any plant can be successfully cultured to regenerate an entire plant; such techniques are described, e.g., in
- Vasil supra Green et al, supra; Weissbach and Weissbach, supra; and Gelvin et al, supra.
- a cloned CDPK polypeptide (or PK domain or CaM-K) construct under the control of the nos promoter and the nopaline synthase terminator and carrying a selectable marker (for example, kanamycin resistance) is transformed into Agrobacterium. Transformation of leaf discs (for example, of tobacco or potato leaf discs), with vector- containing Agrobacterium is carried out as described by Horsch et al. (Science 227: 1229, 1985). Putative transformants are selected after a few weeks (for example, 3 to 5 weeks) on plant tissue culture media containing kanamycin (e.g. 100 ⁇ g/mL). Kanamycin-resistant shoots are then placed on plant tissue culture media without hormones for root initiation.
- kanamycin e.g. 100 ⁇ g/mL
- Kanamycin-resistant plants are then selected for greenhouse growth. If desired, seeds from self- fertilized transgenic plants can then be sowed in a soil-less medium and grown in a greenhouse. Kanamycin-resistant progeny are selected by sowing surfaced sterilized seeds on hormone-free kanamycin-containing media. Analysis for the integration of the transgene is accomplished by standard techniques (see, for example, Ausubel et al. supra; Gelvin et al. supra).
- Transgenic plants expressing the selectable marker are then screened for transmission of the transgene DNA by standard immunoblot and DNA detection techniques. Each positive transgenic plant and its transgenic progeny are unique in comparison to other transgenic plants established with the same transgene. Integration of the transgene DNA into the plant genomic DNA is in most cases random, and the site of integration can profoundly affect the levels and the tissue and developmental patterns of transgene expression.
- transgenic lines are usually screened for each transgene to identify and select plants with the most appropriate expression profiles.
- Transgenic lines are evaluated for levels of transgene expression. Expression at the RNA level is determined initially to identify and quantitate expression-positive plants. Standard techniques for RNA analysis are employed and include PCR amplification assays using oligonucleotide primers designed to amplify only transgene RNA templates and solution hybridization assays using transgene-specific probes (see, e.g., Ausubel et al, supra). The RNA-positive plants are then analyzed for protein expression by Western immunoblot analysis using specific antibodies (see, e.g., Ausubel et al, supra). In addition, in situ hybridization and immunocytochemistry according to standard protocols can be done using transgene-specific nucleotide probes and antibodies, respectively, to localize sites of expression within transgenic tissue.
- the recombinant regulator protein e.g., CDPK, PK domain, or CaM-K
- a transgenic plant for example, as described above
- an anti-regulator polypeptide antibody e.g., produced as described in Ausubel et al, supra, or by any standard technique
- Lysis and fractionation of regulator-producing cells prior to affinity chromatography may be performed by standard methods (see, e.g., Ausubel et al, supra).
- the recombinant protein can, if desired, be further purified, for example, by high performance liquid chromatography (see, e.g., Fisher, Laboratory Techniques In Biochemistry And Molecular Biology, eds. Work and Burdon, Elsevier, 1980).
- plasmid constructs designed for the expression of regulator gene products are useful for generating transgenic plants having an increased level of tolerance to environmental stress. To achieve such tolerance, it is important to express a regulator gene product at an effective level. Evaluation of the level of stress protection conferred to a plant by expression of regulator gene is determined according to conventional methods and assays.
- constitutive expression of the PK domain gene in tomato is used to enhance salt stress tolerance.
- a plant expression vector is constructed that contains a PK cDNA sequence expressed under the control of the nos promoter, a low constitutive promoter. This expression vector is then used to transform tomato according to standard methods.
- transformed tomato plants and appropriate controls are evaluated according to methods described in Lilus et al. (BioTechnology 14: 177, 1996) and Tarczynski et al. (Science 259:508, 1993).
- Transformed tomato plants that express a PK domain gene having an increased level of salt tolerance relative to control plants are taken as being useful in the invention.
- the invention described herein is useful for a variety of agricultural and commercial purposes including, but not limited to, improving tolerance to a variety of environmental stresses, including but not limited to, drought, salinity, cold, and heat, increasing crop yields, improving crop and ornamental quality, and reducing agricultural production costs.
- a regulator gene e.g., a CDPK, a PK domain, or a CaM-K gene
- the invention therefore affords a means for producing plants that can live in environments where growth would otherwise be impaired by adverse environmental factors.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Abstract
Disclosed are methods for increasing a plant's tolerance to environmental stress.
Description
STRESS-PROTECTED TRANSGENIC PLANTS
Statement as to Federally Sponsored Research This invention was made in part with Government funding, and the Government therefore has certain rights in the invention.
Background of the Invention This invention relates to the fields of plant genetic engineering and crop protection.
In both monocot and dicot plants, the stress hormone abscisic acid (ABA) or environmental stress conditions such as drought, cold, and salinity can induce the expression of a number of highly conserved genes in vegetative tissues. The accumulation of these gene products is thought to protect plants from stress induced damage. Many of these genes are also expressed at the late stage of embryogenesis during seed development and are thought to be important for seed desiccation and dormancy. Several studies have identified cis-acting elements and trans-acting factors important for the regulation of these stress-inducible genes. Background information relating to the aforementioned topics is found in the following references: Skriver and Mundy, Plant Cell 2:503, 1990; Bray, Plant Physiol. 103: 1035, 1993; Thomas and Bohnert, Plant Physiol. 103 : 1299, 1993; Chandler and Robertson, Ann. Rev. Plant Physiol. Plant Mol. Biol. 45:113, 1994; Daugherty et al., In Arabidopsis, Somerville and Meyerowitz, Eds. (CSH, CSHL, 1994), pp. 769- 806; Finkelstein and Zeevaart, In Arabidopsis, Somerville and Meyerowtiz Eds. (CSH, CSHL 1994), pp. 523-553; Giraudat et al., Plant Mol. Biol. 26, 1957,
1994; Rock and Quantrano, Curr. Biol. 4:1013, 1994; Thomashow, In Arabidopsis, Somerville and Meyerowitz, Eds. (CSH, CSHL, 1994) pp. 807- 834; Gosti et al, Mol. Gen. Genet. 246: 10, 1995; and Knight et al., Plant Cell 7:499, 1995; Xu et al, Plant Physiol. 110:249, 1996; Guiltinan et al, Science 250:267, 1990; Finkelstein, Mol. Gen. Genet. 238:401 , 1993; Thomas, Plant Cell 5: 1401, 1993; Parcy et al., Plant Cell 6: 1567, 1994; Hattori et al., Plant J. 7:913, 1995; Hoecker et al, Genes Dev. 9:2459, 1995; McCarty, Rev. Plant Physiol. Plant Mol. Biol. 46:71, 1995; Nambara et al., Development 121 :629, 1995; Nakagawa et al., Plant J. 9:217, 1996; Hattori et al., Genes Dev. 6:609, 1992; Pla et al., Plant Mol. Biol. 24:701 , 1994; Baker et al., Plant Mol. Biol. 24:701, 1994; Yamaguchi-Shinozaki and Shinozaki, Plant Cell 6:251, 1994; Menkens et al., Trend Biochem. Sci. 20:506, 1995; Shen and Ho, Plant Cell 7:295, 1995; Taylor et al, Plant J. 7: 129, 1995; de Vetten and Ferl, Plant J. 7:589, 1995; and Lu et al., Plant Cell 8:847, 1996).
Summary of the Invention
In general, the invention features a method for protecting a plant against an environmental stress, the method including the steps of: (a) producing a transgenic plant cell including a recombinant protein kinase (PK) domain gene integrated into the genome of the transgenic plant cell and positioned for expression in the plant cell; and (b) growing a transgenic plant from the plant cell, wherein the PK domain gene is expressed in the transgenic plant. In a preferred embodiment, the method of the invention involves the expression of a PK domain gene which is capable of increasing the level of tolerance to an environmental stress, e.g., dehydration, salt, or temperature stress. In other preferred embodiments, the invention includes a PK domain gene which encodes a polypeptide that includes an amino acid sequence that is
substantially identical to the amino acid sequence of ATCDPK1 or ATCDPKla. In still other preferred embodiments, the invention includes a gene encoding a polypeptide having a PK domain that includes an amino acid sequence that is substantially identical to the amino acid sequence of ATCDPK1 or ATCDPKla.
In another aspect, the invention features a method for protecting a plant against environmental stress, the method including the steps of: (a) producing a transgenic plant cell including a recombinant calcium-dependent protein kinase (CDPK) gene integrated into the genome of the transgenic plant cell and positioned for expression in the plant cell, the CDPK gene being capable of increasing the level of tolerance to an environmental stress, e.g., dehydration, salt, and temperature stresses; and (b) growing a transgenic plant from the plant cell, wherein the CDPK gene is expressed in the transgenic plant. In another aspect, the invention features a method for protecting a plant against environmental stress, the method including the steps of: (a) producing a transgenic plant cell including a recombinant calcium/calmodulin- dependent (CaM-K) gene integrated into the genome of the transgenic plant cell and positioned for expression in the plant cell; and (b) growing a transgenic plant from the plant cell wherein the CaM-K gene is expressed in the transgenic plant. In a preferred embodiment, the method of the invention includes the expression of a CaM-K gene (e.g., a mammalian CaM-KII gene) which is capable of increasing the level of tolerance to an environmental stress, e.g., against dehydration, salt, or temperature stress. In yet another aspect, the invention features a method for protecting a plant against environmental stress, the method including the steps of: (a) producing a transgenic plant cell which includes a combination of at least two
genes selected from the group consisting of a recombinant PK domain gene, a recombinant CDPK gene, and a CaM-K gene, each of the genes being integrated into the genome of the transgenic plant cell and positioned for expression in the plant cell; and (b) growing a transgenic plant from the plant cell, wherein each of the genes is expressed in the transgenic plant. In one preferred embodiment, the method of the invention includes the expression of genes which are capable of increasing the level of tolerance to an environmental stress, e.g., dehydration, salt, or temperature stress.
In another aspect, the invention features a transgenic plant including a recombinant PK domain gene integrated into the genome of the transgenic plant and positioned for expression in the plant, the PK domain gene being capable of increasing the level of tolerance to an environmental stress, e.g., dehydration, salt, or temperature stress, on a transgenic plant expressing the recombinant PK domain. In another aspect, the invention features a transgenic plant including a recombinant CDPK gene integrated into the genome of the transgenic plant and positioned for expression in the plant, the recombinant CDPK gene being capable of increasing the level of tolerance to an environmental stress, e.g., dehydration, salt, or temperature stress, on a transgenic plant expressing the recombinant CDPK.
In another aspect, the invention features a transgenic plant including a recombinant CaM-K gene integrated into the genome of the transgenic plant and positioned for expression in the plant, the recombinant CaM-K gene being capable of increasing the level of tolerance to an environmental stress, e.g., dehydration, salt, or temperature stress, on a transgenic plant which is expressing the recombinant CaM-K gene.
In another aspect, the invention features a transgenic plant including
a recombinant CDPK gene, PK domain gene, CaM-K gene, or any combination thereof integrated into the genome of the transgenic plant cell and positioned for expression in the plant cell, the CDPK, PK domain, and CaM-K genes being capable of increasing the level of tolerance to an environmental stress, e.g., dehydration, salt, or temperature stress, on a transgenic plant expressing the DNA.
In yet other aspects, the invention includes seeds and cells from any of the aforementioned transgenic plants.
In still other aspects, the invention features a substantially pure PK domain polypeptide capable of increasing the level of tolerance to an environmental stress, e.g., environmental stress in a transgenic plant. In one embodiment, the invention features a PK domain polypeptide including an amino acid sequence substantially identical to the amino acid sequence shown in Fig. 5 (SEQ ID NO: 2). In another aspect, the invention features substantially pure DNA encoding a PK domain polypeptide capable of conferring tolerance to an environmental stress in a transgenic plant. This DNA may include a nucleic acid sequence substantially identical to the nucleic acid sequence shown in Fig. 5 (SEQ ID NO: 1). Such DNA may be operably linked to an expression control region for the expression of the PK polypeptide; and the expression control region may include a promoter (for example, a constitutive or inducible promoter).
In yet another aspect, the invention features a cell (e.g., a plant cell) which includes the DNA of the invention. By "polypeptide" is meant any chain of amino acids, regardless of length or post-translational modification (for example, glycosylation or phosphorylation).
By "substantially identical" is meant a polypeptide or nucleic acid exhibiting at least 70%, preferably 80%, more preferably 85%, and most preferably 90%, or even 95% sequence identity to a reference sequence. For polypeptides, the length of comparison sequences will generally be at least 16 amino acids, preferably at least 20 amino acids, more preferably at least 25 amino acids, and most preferably 35 amino acids. For nucleic acids, the length of comparison sequences will generally be at least 50 nucleotides, preferably at least 60 nucleotides, more preferably at least 75 nucleotides, and most preferably 110 nucleotides. Sequence identity is typically measured using sequence analysis software (for example, Sequence Analysis Software Package of the Genetics Computer Group, University of Wisconsin Biotechnology Center, 1710 University Avenue, Madison, WI 53705, BLAST, FastA, or PILEUP/PRETTYBOX programs). Such software matches identical or similar sequences by assigning degrees of homology to various substitutions, deletions, and/or other modifications. Conservative substitutions typically include substitutions within the following groups: glycine alanine; valine, isoleucine, leucine; aspartic acid, glutamic acid, asparagine, glutamine; serine, threonine; lysine, arginine; and phenylalanine, tyrosine. By a "substantially pure polypeptide" is meant a polypeptide (for example, the PK domain polypeptide shown in Fig. 5 (SEQ ID NO: 2)) that has been separated from components which naturally accompany it. Typically, the polypeptide is substantially pure when it is at least 60%, by weight, free from the proteins and naturally-occurring organic molecules with which it is naturally associated. Preferably, the preparation is at least 75%, more preferably at least 90%, and most preferably at least 99%, by weight, a substantially pure polypeptide. For example, a substantially pure PK domain
polypeptide may be obtained, for example, by extraction from a natural source (for example, a plant cell); by expression of a recombinant nucleic acid encoding a PK domain polypeptide; or by chemically synthesizing the protein. Purity can be measured by any appropriate method, for example, column chromatography, polyacrylamide gel electrophoresis, or by HPLC analysis.
By "derived from" is meant isolated from or having the sequence of a naturally-occurring sequence (e.g., a cDNA, genomic DNA, synthetic DNA, or combination thereof).
By "substantially pure DNA" is meant DNA that is free of the genes which, in the naturally-occurring genome of the organism from which the DNA of the invention is derived, flank the gene. The term therefore includes, for example, a recombinant DNA that is incorporated into a vector; into an autonomously replicating plasmid or virus; or into the genomic DNA of a prokaryote or eukaryote; or that exists as a separate molecule (for example, a cDNA or a genomic or cDNA fragment produced by PCR or restriction endonuclease digestion) independent of other sequences. It also includes a recombinant DNA which is part of a hybrid gene encoding additional polypeptide sequence.
By "transformed cell" is meant a cell into which (or into an ancestor of which) has been introduced, by means of recombinant DNA techniques, a DNA molecule encoding (as used herein) a regulator polypeptide (e.g., a CDPK, a PK domain, or a CaM-K polypeptide).
By "positioned for expression" is meant that the DNA molecule is positioned adjacent to a DNA sequence which directs transcription and translation, if appropriate, of the sequence (i.e., facilitates the production of, for example, a CDPK polypeptide, a PK domain polypeptide, a CaM-K polypeptide, a recombinant protein, or an RNA molecule).
By "reporter gene" is meant a gene whose expression may be assayed; such genes include, without limitation, β-glucuronidase (GUS), luciferase, chloramphenicol transacetylase (CAT), green fluorescent protein (GFP), and β-galactosidase. By "expression control region" is meant any minimal sequence sufficient to direct transcription. Included in the invention are promoter elements that are sufficient to render promoter- dependent gene expression controllable for cell-, tissue-, or organ-specific gene expression, or elements that are inducible by external signals or agents (for example, light-, pathogen-, wound-, stress-, or hormone-inducible elements or chemical inducers such as SA or INA); such elements may be located in the 5' or 3' regions of the native gene or engineered into a transgene construct.
By "operably linked" is meant that a gene and a regulatory sequence(s) are connected in such a way as to permit gene expression when the appropriate molecules (for example, transcriptional activator proteins) are bound to the regulatory sequence(s).
By "plant cell" is meant any self-propagating cell bounded by a semi- permeable membrane and containing a plastid. Such a cell also requires a cell wall if further propagation is desired. Plant cell, as used herein includes, without limitation, algae, cyanobacteria, seeds, suspension cultures, embryos, meristematic regions, callus tissue, leaves, roots, shoots, gametophytes, sporophytes, pollen, and microspores.
By "crucifer" is meant any plant that is classified within the Cruciferae family. The Cruciferae include many agricultural crops, including, without limitation, rape (for example, Brassica campestris and Brassica napus), broccoli, cabbage, Bmssel sprouts, radish, kale, Chinese kale, kohlrabi, cauliflower, turnip, rutabaga, mustard, horseradish, and Arabidopsis.
By "transgene" is meant any piece of DNA which is inserted by artifice into a cell, and becomes part of the genome of the organism which develops from that cell. Such a transgene may include a gene which is partly or entirely heterologous (i.e., foreign) to the transgenic organism, or may represent a gene homologous to an endogenous gene of the organism.
By "transgenic" is meant any cell which includes a DNA sequence which is inserted by artifice into a cell and becomes part of the genome of the organism which develops from that cell. As used herein, the transgenic organisms are generally transgenic plants and the DNA (transgene) is inserted by artifice into the nuclear or plastidic genome.
By "increased level of tolerance to environmental stress" is meant a greater level of tolerance to an environmental stress (e.g., drought, salinity, and temperature stress) than that exhibited by a control plant (for example, a non- transgenic plant). Preferably, the level of stress tolerance in a transgenic plant of the invention is at least 5%, 10%, or 20% (and preferably 30% or 40%) greater than the tolerance to an environmental stress exhibited in a control plant. In other preferred embodiments, the level of tolerance to an environmental stress is 50% greater, 60% greater, and more preferably even 75% or 90% greater than a control plant; with up to 100% above the level of tolerance as compared to a control plant being most preferred. The level of tolerance is measured using conventional methods. For example, the level of stress tolerance to salinity may be determined by comparing physical features and characteristics (for example, plant height and weight) of transgenic plants and control plants. The invention provides a number of important advances and advantages for the protection of plants against environmental stress, such as drought, salt, and temperature. For example, the invention facilitates an
effective and economical means to improve agronomically important traits of plants for tolerating the effects of dehydration, salinity, cold, and heat. The invention provides for increased production efficiency, as well as for improvements in quality and yield of crop plants and ornamentals. Thus, the invention contributes to the production of high quality and high yield agricultural products: for example, fruits, ornamentals, vegetables, cereals, and field crops. Genetically-improved seeds and other plant products that are produced using plants expressing the genes described herein also render farming possible in areas previously unsuitable for agricultural production. The invention further provides a means for mediating the expression of stress- related protective proteins that enable a plant to tolerate the effects of environmental stress. For example, transgenic plants constitutively producing a recombinant CDPK gene product, a PK domain, or CaM-K are capable of turning on a plant's stress signal transduction pathway by allowing the expression of multiple stress-related proteins, which in turn enhances the plant's tolerance to multiple stress conditions. Expression of these gene products therefore obviates the need to express individual stress-related genes as a means to promote plant defense mechanisms against adverse conditions.
Other features and advantages of the invention will be apparent from the following description of the preferred embodiments thereof, and from the claims.
Detailed Description The drawings will first be described. Drawings Fig. 1 shows a series of photographs demonstrating stress signaling
in maize leaf protoplasts as visualized by green-fluorescent (GFP) expression.
Fig. 2 shows a series of photographs demonstrating that intracellular Ca2+ elevation activates stress signaling.
Fig. 3 A shows a schematic illustration of the structural comparison between plant CDPKs and mammalian CaMKII.
Fig. 3B shows the sequence comparison among the kinase domains of four ATCDPKs. Identical amino acids are highlighted.
Fig. 3C shows the schematic illustrations of various PK constructs.
Fig. 3D shows a photograph of a gel illustrating the immunoprecipitation of eight PKs with anti-HA. Lane 0, background control; Lane 1, ATCDPK; Lane 2, ATCDPK1; Lane 3, ATCDPKla; Lane 4, ATCDPK2; Lane 5, ATPKa; Lane 6, ATPKb, Lane 7, ASKl ; Lane 8, ASK2, Lane M, protein molecular weight markers (92, 66, 43, 27, 18, 14 kD).
Fig. 3E shows a graph demonstrating that ATCDPK1 and ATCDPKla activate stress-inducible transcription.
Fig. 4A shows a photograph of a gel illustrating the immunoprecipitation of ATCDPK1 and ATCDPK1(K40M) mutant proteins.
Fig. 4B shows a series of photographs demonstrating that the ATCDPK1 (K40M) mutant does not activate stress signaling. Fig. 4C shows a graph demonstrating that PP2C blocks the action of
CDPK1.
Fig. 4D shows a schematic illustration of a model for stress signal transduction in plant cells.
Fig. 5 shows the nucleotide and amino acid sequences of the ATCDPKla PK domain, SEQ ID NO: 1 and SEQ ID NO: 2, respectively.
Overview
Evidence is presented below showing that constitutively active mutants of two closely related Ca2+dependent protein kinases (CDPKl and CDPKl a) activate a stress-inducible promoter, bypassing stress signals. The effects of CDPKl and CDPKl a are specific since six distinct plant protein kinases, including two other CDPKs, failed to mimic stress signaling. The activation is abolished by a CDPKl mutation in the kinase domain, and diminished by a constitutively active protein phosphatase 2C capable of blocking the stress hormone ABA responses. The results indicate that CDPKs (including their PK domains) play distinct physiological roles. CDPKl and CDPKl a are therefore examples of positive regulators for controlling stress signal transduction in plants. Expression of such regulators in transgenic plants is useful for turning on the stress signal transduction pathway as a means for increasing plant tolerance to multiple stress conditions, including drought, salinity, and extreme temperature conditions.
Stress Signaling in Maize Leaf Protoplasts Visualized by GFP Expression
Responses to multiple stress treatments were monitored using green- fluorescent protein (GFP) as a vital reporter (Chiu et al. Curr. Biol. 6:225, 1996), using a single cell maize leaf protoplast system (Sheen, EMBO J 12:3497, 1993). A chimeric gene was generated by fusing the stress-inducible CDPK HVA1 promoter (Straub et al. Plant Mol. Biol. 26:617, 1994) to a synthetic GFP sequence (HVA1-SGFP) (Chiu et al. Curr. Biol. 6:225, 1996). The barley HVA1 promoter was obtained by PCR using barley genomic DNA and two primers: 5TCCACCGAGATGCCGACGCA-3' (SEQ ID NO: 17) and 5'-GTTGGAGGCCATGGTCGTCTCACGAT-3' (SEQ ID NO: 18). The
HVA1 promoter and the SGFP were fused at the ATG Ncol site. The CDPK
HVA1 gene has been reported to be activated by multiple stress signals in vegetative tissues (Straub et al., Plant Mol. Biol. 26:617, 1994). Four clones were selected and tested for stress responses with identical results as is discussed below. Maize leaf protoplasts were electroporated with the plasmid DNA carrying HVA1-SGFP and divided (105 cells/ml per sample) for various treatments: constant light (15 μEm"2S"') at 23 °C for sixteen hours (Control), 0°C for four hours followed by twelve hours at 23 °C (Cold), 0.2 M NaCl for three hours, washed, and incubated for thirteen hours (Salt), constant darkness for sixteen hours (Dark), and 100 μM ABA for sixteen hours (ABA) (Fig. 1). The protocol for transient expression analysis using maize leaf protoplasts has been described by Sheen (EMBO J. 12: 3497, 1993) and Chiu et al. (Curr. Biol. 6:225, 1996). About 105 protoplasts from each treatment were observed using a fluorescence microscope as described by Chiu et al. (Curr. Biol. 6:225, 1996). The experiment was repeated three times with similar results. About 50% of the protoplasts, showing green/yellow fluorescence after the induction, were transiently transformed. Control and untransfected protoplasts showed red auto fluorescence from chlorophyll. GFP expression was visible with 1 μM ABA (data not shown). In addition, after electroporation of the plasmid DNA carrying
HVA1-SGFP into maize leaf protoplasts, the expression of GFP was found to be enhanced by cold, high salt, dark, and ABA (Fig. 1). These responses were specific to HVA1-SGFP because the expression of an internal control, generated by fusing the maize ubiquitin promoter (Christensen et al., Plant Mol. Biol. 18:675, 1992) and the β-glucuronidase gene (UBI-GUS) (Jefferson, Plant Mol. Biol. Rep. 5:387, 1987), was not affected (data not shown). In addition, the GFP expression derived from UBI-SGFP was not changed by the same
treatments (data not shown).
Intracellular Ca2+ Elevation Activates Stress Signaling
The role of Ca2+ as a second messenger in multiple stress responses was also studied. The effects of increased intracellular Ca2+ on HVA1-SGFP expression in maize leaf protoplasts using Ca2+ ionophore was examined using standard methods as described below (Knight et al. Nature 352:524, 1991 ;
Schroeder and Thuleau, Plant Cell 3:555, 1991 ; Braam, Proc. Natl. Acad. Sci.
U.S.A. 89:3213, 1992; McAinsh et al. Plant Cell 4: 1113, 1992; Assmann, Ann.
Rev. Cell Biol. 9:345, 1993; Poovaiah and Reddy, Crit. Rev. Plant Sci. 12: 185, 1993; Trewavas and Knight, Plant Mol. Biol. 26: 1329, 1994; Ward and
Schroeder, Plant Cell 6:669, 1994; Bethke et al, in Plant Hormones, Davies,
Ed, (Kluwer Academic 1995) pp. 298-317; Bush, Ann. Rev. Plant Physiol.
Plant Mol. Biol. 46:95, 1995; Monroy and Dhindsa, Plant Cell 7:32, 1995; and
Knight et al. Plant Cell 8:489, 1996). Maize leaf protoplasts transfected with HVA1-SGFP (HVA) or UBI-
SGFP (UBI) were treated with 1 mM Ca2+, 1 mM Ca27l 00 nM A23187, and 1 mM Ca2+/100 nM ionomycin, respectively designated "C," "A," and "I" in Fig.
2. UBI-SGFP was constructed by inserting the UBI promoter from pAHC27
(Christensen et al. Plant Mol. Biol. 18:675, 1992) into the SGFP vector (Chiu et al, Curr. Biol. 6:225, 1996). Protoplast transient expression is the same as described by Sheen (EMBO J. 12: 3497, 1993) and Chiu et al. (Curr. Biol.
6:225,1996). About 105 protoplasts from each treatment were observed using a fluorescence microscope (Chiu et al, Curr. Biol. 6:225, 1996). The experiment was repeated twice with similar results. As shown in Fig. 2, the expression of HVA 1 -GFP was significantly increased by the Ca27ionomycin and Ca2+/A23187, but not by Ca2+ alone in the
incubation medium. This activation is specific because the same treatment did not influence UBI-SGFP expression (Fig. 2), but was found to inhibit the expression of GFP controlled by a stress-repressible photosynthetic gene promoter (Sheen, EMBO J. 12:3497, 1993; data not shown).
Constitutive ATCDPKl and ATCDPKla Activate Stress Signal Transduction To determine whether Ca2+ activated protein kinases (PKs) play a role in stress signal transduction in plants, the effect of co-expressing four constitutively active Ca2+-dependent protein kinases (CDPKs) on the HVA1 promoter activity was examined. As is shown in Fig. 3A, plant CDPKs share extensive sequence identity with the mammalian multifunctional
Ca27calmodulin-dependent KPII (CaMKII) (Kapiloff et al, Proc. Natl. Acad. Sci. USA 88:3710, 1991). However, instead of bearing a calmodulin binding site, this family of PKs carries a calmodulin-like domain at the C-terminus (Fig. 3A). This unique feature presumably allows CDPKs to respond to Ca2+ signals directly without calmodulin. Various other domains found in CaMKII and CDPK are shown in Fig. 3A, these include: (H) hinge, (N) NH2. terminal domain for some CDPKs (J) junction, (EF) EF-hand Ca2+-binding site (Harper et al. Science 252:951 , 1991; Suen and Choi, Plant Mol. Biol. 17:581, 1991 ; Roberts and Harmon, Ann. Rev. Plant Physiol. Plant Mol. Biol. 43:375, 1992; Estruch et al, Proc. Natl. Acad. Sci. USA 91 :8837, 1994; Urao et al. Plant Physiol. 105: 1461, 1994; Urao et al, Mol. Gen. Genet. 244:331, 1994; Harper et al, Bioch. 33:7267, 1994; and Kapiloff et al, Proc. Natl. Acad. Sci. USA 88:3710, 1991). Currently, CDPKs are the most prevalent serine/threonine PKs found in higher plants as the cloning of numerous CDPKs in a broad range of plant species has been reported (Harper et al. Science 252:951, 1991 ; Suen and Choi, Plant Mol. Biol. 17:581 , 1991; Roberts and Harmon, Ann. Rev. Plant
Physiol. Plant Mol. Biol. 43:375, 1992; Estruch et al, Proc. Natl. Acad. Sci. USA 91 :8837, 1994; Urao et al. Plant Physiol. 105: 1461, 1994; Urao et al, Mol. Gen. Genet. 244:331, 1994; Harper et al, Biochem. 33:7267, 1994). Eight Arabidopsis PKs with full-length coding sequences were chosen for the following experiments (Urao et al, Mol. Gen. Genet. 244:331, 1994; Harper et al, Bioch. 33:7267, 1994; Minet et al. Plant J. 2:417, 1992; Anderberg and Walker- Simmons, Proc. Natl. Acad. Sci. USA 89: 10183, 1992; Park et al. Plant Mol. Biol. 22:615, 1993; Holappa and Walker-Simmons, Plant Physiol. 108: 1203, 1995). Two CDPKs (ATCDPKl and ATCDPKla) are closely related (96% amino acid and similarity) while the other two CDPKs (AKl/ATCDPK and ATCDPK2 have more divergent sequences (78% and 75% amino acid similarity respectively, to ATCDPKl) (Fig. 3B). In vitro assays showed that AKl/ATCDPK and ATCDPK2 possess calcium-dependent PK activity and the truncated AKl/ATCDPK has calcium-independent (constitutively active) PK activity by (Urao et al, Mol. Gen. Genet. 244:331 , 1994; and Harper et al, Bioch. 33:7267, 1994). The PK activity of ATCDPKl, however, has not been demonstrated in vitro because it does not phosphorylate common PK substrates (Urao et al, Mol. Gen. Genet. 244:331, 1994). The ATCDPKla cDNA that has restriction enzyme digestion patterns distinct from those of ATCDPKl , was identified during the isolation of ATCDPKl by polymerase chain reaction (PCR) (Minet et al. Plant J. 2:417,1992). The nucleotide and amino acid sequences of the ATCDPKla PK are shown in Fig. 5 (SEQ ID NO: 1 and 2, respectively). The effect of four other Arabidopsis PKs (ATTPKa, ATPKb, ASKQ, ASK2) that share significant homology with the ABA-inducible PK (PKABA1), speculated to mediate ABA signal transduction, were also tested (Anderberg and Walker- Simmons, Proc. Natl. Acad. Sci. USA 89: 10183, 1992;
Park et al. Plant Mol. Biol. 22:615, 1993; Holappa and Walker-Simmons, Plant Physiol. 108: 1203, 1995). These PK cDNAs were obtained by PCR, and at least two clones of each cDNA were used for transient expression analysis. PK cDNAs were obtained by PCR using an Arabidopsis cDNA library. The primers for these reactions were: (AKl/ATCDPK) 5'-
GAAGATCTATGGGTAATACTTGTGTTGGA-3' (SEQ ID NO: 3) and 5'- GTCAAGGCCTGTCGACTTGAACCCATGG-3' (SEQ ID NO: 4); (ATCDPKl) and (ATCDPKAla) 5'-GCGGATCCATGGCTAATCAAACTCAGATCAGCG-3' (SEQ ID NO: 5 ) and 5'-GTCAAGGCCTCATCAGTGAGAACATGTTC-3* (SEQ ID NO: 6); (ATCDPK2) 5'-
GCGGATCCATGGAGACGAAGCCAAACCCTA-3' (SEQ ID NO: 7) and 5*- GTCAAGGCCTTGCTTGTTCATCGACAATCC-3' (SEQ ID NO: 8 ); (ATPKa) 5'-CATGCCATGGCTCCGGCGACTAATTCACCG-3' (SEQ ID NO: 9) and
5'-GTCAAGGCCTATTCTTCAAGAACCATTTATCG-3' (SEQ ID NO: 10); (ATPKb) 5'GCGGATCCATGGCTCGAGCTCCGGTGACCA-3 (SEQ ID NO: 11) and 5'-GTCAAGGCCTATTCTTCAAGAACCAACTATG-3' (SEQ ID NO: 12); (ASKl) 5'- GCGGATCCATGGCTAAGTCAGAGCTGGTGAAAG-3' (SEQ ID NO: 13) and 5'-GTCAAGGCCTATTCTTTAGGAACCATGAATG-3' (SEQ ID NO: 14); (ASK2 5'-GCGGATCCATGGCTAAGTATGACGTTGTCAAGG-3' (SEQ ID NO: 15) and GTCAAGGCCTATTCTTCAAGTACCACGG-3' (SEQ ID NO: 16). The sequence of ATCDPKAla was determined for both strands using an automatic sequencing facility.
Truncated forms containing all eleven PK domains, analogous to the construction of a constitutively active mutant of CaMKII in mammals (Kapiloff
et al, Proc. Natl. Acad. Sci. 88, 7267, 1994) (Fig. 3 A and Fig. 3B), were inserted into the plant expression vector with a strong constitutive promoter 35SC4PPDK (Sheen, EMBO J 12:3497, 1993; Chiu et al. Curr. Biol. 6:225,1996). The putative regulatory domains of theses PKs were deleted (Fig. 3C). To allow convenient monitoring of protein expression, these PKs were fused in frame to a double hemagglutinin (HA) epitope tag (designated DHA in Fig. 3C) at the C-terminus and inserted into a plant expression vector (Sheen, EMBO J. 12:3497, 1993; and Chiu et al, Curr. Biol. 6:225, 1996).
The expression of eight PKs in transfected maize leaf protoplasts were demonstrated by immunoprecipitation of [35S] methionine labeled proteins with the anti-HA monoclonal antibody (Fig. 3D). Transfected protoplasts were incubated for four hours to allow mRNA accumulation and then labeled with 200 μCi/ml of [35S] methionine for twelve hours before harvest. Immunoprecipitation was carried out based on a published protocol by Kapiloff et al. (Proc. Natl. Acad. Sci. USA 88:3710, 1991). The proteins were separated on a 12.5% SDS-PAGE gel and visualized by fluorography. All PK constructs yielded strong bands, approximately 30-35 kD for 2-8 and around 55 kD for AKl/ATCDPK, indicating that all transgenes were expressed efficiently (Fig. 3D). For quantitating the effect of various constitutive PKs on stress signaling, another chimeric gene with the HVA1 promoter and the luciferase coding sequence (Leuhrsen et al, Meth. Enz. 216:397, 1992) (HVA1-LUC) was generated. Co-expression experiments were performed by electroporating the reporter (HVA1-LUC) and the effector (35SC4PSK-PK-HA) plasmids together into maize leaf protoplasts as follows.
Maize leaf protoplasts were transfected with HVA 1 -LUC alone and incubated without (Fig. 3E, "C") or with 100 μM ABA (Fig. 3E, "A"). HVA1-
LUC was also co-electroporated with the PK constructs (1-8) shown in Fig. 3C and Fig. 3D, and incubated without ABA (Fig. 3E, "1-8"). Relative LUC activities from duplicated samples are shown. About 2% of the cell lysates were used for LUC (Luehrsen et al, Meth. Enz. 216:397, 1992) and GUS assays (Sheen, EMBO J. 12:3497, 1993; and Jefferson, Plant Mol. Biol. Rep. 5:387, 1987). The experiment was repeated three times with similar results. The results showed that ATCDPKl and ATCDPKla, but not the other six PKs, could specifically activate LUC expression controlled by the HVA1 promoter (Fig. 3E). An identical set of PKs without the HA tag gave the same results (data not shown). The expression of UBI-GUS as an internal control was not affected (data not shown).
CDPKl Activates but PP2C Abolishes Stress Signaling
To show that PK activity is important for the activation of the stress- inducible HVA1 promoter, a null mutation was made by site-directed mutagenesis to eliminate the ATP binding site (K40) in ATCDPKl (Urao et al, Mol. Gen. Genet. 244:331 , 1994; and Kapiloff et al, Proc. Natl. Acad. Sci. USA 88:3710, 1991) and analyzed as follows. Maize leaf protoplasts were electroporated with HVA1-SGFP alone, or with ATCDPKl (CDPKl) and the ATCDPKl (K40M) mutant (CDPKlmut). About 105 protoplasts from each treatment were observed using a fluorescence microscope (Chiu et al, Curr.
Biol. 6:225, 1996). About 50% of the protoplasts were transiently transformed.
The kinase mutation (K40M) did not affect the expression of the protein (Fig. 4A), but it could no longer activate the expression of HVA1-GFP (Fig. 4B). The expression of UBI-SGFP was not affected by ATCDPKl or the ATCDPKl mutant (data not shown). This result indicates that the PK domain
of ATCDPKl was required and sufficient to recognize specific protein substances mediating stress signal transduction. The deleted regulatory domain was likely involved in PK activity control in response to stress signals (Harper et al. Science 252:951, 1991 ; Suen and Choi, Plant Mol. Biol. 17:581, 1991 ; Roberts and Harmon, Ann. Rev. Plant Physiol. Plant Mol. Biol. 43:375, 1992; Estruch et al, Proc. Natl. Acad. Sci. USA 91 :8837, 1994; Urao et al. Plant Physiol. 105: 1461, 1994; Urao et al, Mol. Gen. Genet. 244:331, 1994; Harper et al, Bioch. 33:7267, 1994; and Kapiloff et al, Proc. Natl. Acad. Sci. USA 88:3710, 1991). To further support the idea that ATCDPKl and ATCDPKl a are positive regulators in plant stress signal transduction, the effect of a specific and constitutively active Arabidopsis protein phosphatase 2C (PP2C) capable of abolishing ABA responses (Leung et al. Science 264: 1448, 1994; Meyer et al. Science 264: 1452, 1994; Armstrong et al, Proc. Natl. Acad. Sci. USA 92:9520, 1995) was examined as follows. Maize leaf protoplasts were electroporated with HVA 1 -LUC alone or with the effectors as indicated. PP2C null did not show PP2C activity (data not shown). The experiments with the constitutively active PP2C or the null PP2C were performed with two concentrations of plasmid DNA (+, 20 μg and ++, 60 μg) (Fig. 4C). LUC and GUS assays were performed with 2% of the cell lysates as described previously by Sheen (EMBO J. 12:3497, 1993; Jefferson, Plant Mol. Biol. Rep. 5:387, 1987; and Luehrsen et al, Meth. Enz. 216:397, 1992). Relative LUC activities from duplicated samples are shown. The experiment was repeated three times with similar results (Fig. 4C). HVA 1 -LUC expression activated by ABA was significantly repressed by the constitutively active PP2C. Constitutive PP2C, but not its null version diminished, but did not completely abolish, HVA 1 -LUC expression
enhanced by ATCDPKl (Fig. 4C). Other serfne/fhreonine PPs such as PP1, PP2A and PP2B might be required to completely counteract the effect of ATCDPKl , which could be a convergent point of multiple stress signaling (Fig. 4D). The same results were obtained with ATCDPKl A, and the expression of the intemal control UBI-GUS were not affected (data not shown). As the genes involved in stress responses are highly conserved in plants, the role of ATCDPKl and ATCDPKla in stress signal transduction may extend to various cell types of diverse plant species (Fig. 4D). Thus, the manipulation of specific CDPK activities might have important agricultural applications in preventing and protecting crop plants from stress damage and yield loss.
Isolation of Regulators of the Stress Signal Transduction Response
The isolation of additional stress regulator coding sequences (e.g., CDPK, PK, and CaM-K) having the ability to regulate the stress signal transduction pathway in plants is accomplished using standard strategies and techniques that are well known in the art.
In one particular example, the CDPK sequences described herein may be used, together with conventional screening methods of nucleic acid hybridization screening. Such hybridization techniques and screening procedures are well known to those skilled in the art and are described, for example, in Benton and Davis, Science 196: 180, 1977; Grunstein and Hogness, Proc. Natl. Acad. Sci, USA 72:3961, 1975; Ausubel et al. Current Protocols in Molecular Biology, Wiley Interscience, New York, and Berger and Kimmel, Guide to Molecular Cloning Techniques, 1987, Academic Press, New York.;; and Sambrook et al. Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, New York. In one particular example, all or part of
the CDPK (described herein) may be used as a probe to screen a recombinant plant DNA library for genes having sequence identity to the CDPK gene or the PK domain. Hybridizing sequences are detected by plaque or colony hybridization according to the methods described below. Alternatively, using all or a portion of the amino acid sequence of the
PK polypeptide (SEQ ID NO: 2), one may readily design PK-specific oligonucleotide probes, including PK degenerate oligonucleotide probes (i.e., a mixture of all possible coding sequences for a given amino acid sequence). These oligonucleotides may be based upon the sequence of either DNA strand and any appropriate portion of the PK sequence. General methods for designing and preparing such probes are provided, for example, in Ausubel et al, 1996, Current Protocols in Molecular Biology, Wiley Interscience, New York, and Berger and Kimmel, Guide to Molecular Cloning Techniques, 1987, Academic Press, New York. These oligonucleotides are useful for PK gene isolation, either through their use as probes capable of hybridizing to PK complementary sequences or as primers for various amplification techniques, for example, polymerase chain reaction (PCR) cloning strategies. If desired, a combination of different oligonucleotide probes may be used for the screening of a recombinant DNA library. The oligonucleotides may be detectably- labeled using methods known in the art and used to probe filter replicas from a recombinant DNA library. Recombinant DNA libraries are prepared according to methods well known in the art, for example, as described in Ausubel et al. (supra), or they may be obtained from commercial sources.
As discussed above, PK oligonucleotides may also be used as primers in amplification cloning strategies, for example, using PCR. PCR methods are well known in the art and are described, for example, in PCR Technology, Erlich, ed, Stockton Press, London, 1989; PCR Protocols: A
Guide to Methods and Applications, Innis et al, eds. Academic Press, Inc., New York, 1990; and Ausubel et al. (supra). Primers are optionally designed to allow cloning of the amplified product into a suitable vector, for example, by including appropriate restriction sites at the 5' and 3' ends of the amplified fragment (as described herein). If desired, PK sequences may be isolated using the PCR "RACE" technique, or Rapid Amplification of cDNA Ends (see, e.g., Innis et al. (supra)). By this method, oligonucleotide primers based on an PK sequence are oriented in the 3' and 5' directions and are used to generate overlapping PCR fragments. These overlapping 3'- and 5 '-end RACE products are combined to produce an intact full-length cDNA. This method is described in Innis et al. (supra); and Frohman et al, Proc. Natl. Acad. Sci. USA 85:8998, 1988.
Confirmation of a sequence's relatedness to the PK polypeptide family may be accomplished by a variety of conventional methods including, but not limited to, sequence comparison of the gene and its expressed product. In addition, the activity of the gene product may be evaluated according to any of the techniques described.
Once a regulator of the stress response is identified (e.g., CDPK, PK, or CaM-K sequences), it is cloned according to standard methods and used for the construction of plant expression vectors as described below.
Expression Constructs Encoding Regulators of the Stress Signal Transduction Response
Those skilled in the field of molecular biology will understand that any of a wide variety of expression systems may be used to provide the recombinant protein. The precise host cell used is not critical to the invention. The regulators of the invention (e.g., a CDPK, a PK domain, or a CaM-K) may
be produced in a prokaryotic host, for example, E. coli, or in a eukaryotic host, for example, Saccharomyces cerevisiae, mammalian cells (for example, COS 1 or NIH 3T3 cells), or any of a number of plant hosts including, without limitation, algae, tree species, ornamental species, temperate fruit species, tropical fruit species, vegetable species, legume species, crucifer species, monocots, dicots, or in any plant of commercial or agricultural significance. Particular examples of suitable plant hosts include, but are not limited to, Conifers, Petunia, Tomato, Potato, Tobacco, Arabidopsis, Lettuce, Sunflower, Oilseed rape, Flax, Cotton, Sugarbeet, Celery, Soybean, Alfalfa, Medicago, Lotus, Vigna, Cucumber, Carrot, Eggplant, Cauliflower, Horseradish, Morning Glory, Poplar, Walnut, Apple, Grape, Asparagus, Rice, Maize, Millet, Onion, Barley, Orchard grass, Oat, Rye, and Wheat. In addition, as is discussed below, expression constructs may be expressed in a transgenic plant to turn on the stress signal transduction pathway to enhance plant tolerance to multiple stress conditions.
Materials for expressing these genes are available from a wide range of sources including the American Type Culture Collection (Rockland, MD); or from any of a number seed companies, for example, W. Atlee Burpee Seed Co. (Warminster, PA), Park Seed Co. (Greenwood, SC), Johnny Seed Co. (Albion, ME), or Northrup King Seeds (HarstviUe, SC). Descriptions and sources of useful host cells are also found in Vasil I.K, Cell Culture and Somatic Cell Genetics of Plants, Vol I, II, III Laboratory Procedures and Their Applications Academic Press, New York, 1984; Dixon, R.A, Plant Cell Culture-A Practical Approach, IRL Press, Oxford University, 1985; Green et al. Plant Tissue and Cell Culture, Academic Press, New York, 1987; and Gasser and Fraley, Science 244: 1293, 1989.
The method of transformation or transfection and the choice of
vehicle for expression of the regulator polypeptide (e.g., a CDPK, a PK domain, or a CaM-K) will depend on the host system selected. Transformation and transfection methods are described, e.g., in Ausubel et al. (supra); Weissbach and Weissbach, Methods for Plant Molecular Biology, Academic Press, 1989; Gelvin et al. Plant Molecular Biology Manual, Kluwer Academic Publishers, 1990; Kindle, K, Proc. Natl. Acad. Sci, U.S.A 87:1228, 1990; Potrykus, I, Annu. Rev. Plant Physiol. Plant Mol. Biology 42:205, 1991 ; and BioRad (Hercules, CA) Technical Bulletin #1687 (Biolistic Particle Delivery Systems). Expression vehicles may be chosen from those provided, e.g., in Cloning Vectors: A Laboratory Manual (P.H. Pouwels et al, 1985, Supp. 1987); Gasser and Fraley (supra); Clontech Molecular Biology Catalog (Catalog 1992/93 Tools for the Molecular Biologist, Palo Alto, CA); and the references cited above. Other expression constructs are described by Fraley et al. (U.S. Pat. No. 5,352,605). Most preferably, a regulator polypeptide (e.g. CDPK, PK domain, or
CaM-K) is produced by a stably-transfected plant cell line, a transiently- transfected plant cell line, or by a transgenic plant. A number of vectors suitable for stable transfection of plant cells or for the establishment of transgenic plants are available to the public; such vectors are described in Pouwels et al. (supra), Weissbach and Weissbach (supra), and Gelvin et al. (supra). Methods for constructing such cell lines are described in, e.g., Weissbach and Weissbach (supra), and Gelvin et al. (supra). Typically, plant expression vectors include (1) a cloned plant gene under the transcriptional control of 5' and 3' regulatory sequences and (2) a dominant selectable marker. Such plant expression vectors may also contain, if desired, a promoter regulatory region (for example, one conferring inducible or constitutive, pathogen- or wound-induced, environmentally- or developmentally-regulated,
or cell- or tissue-specific expression), a transcription initiation start site, a ribosome binding site, an RNA processing signal, a transcription termination site, and/or a polyadenylation signal.
Once the desired nucleic acid sequence encoding a regulator polypeptide (e.g., CDPK, PK, or CaM-K sequence) is obtained as described above, it may be manipulated in a variety of ways known in the art. For example, where the sequence involves non-coding flanking regions, the flanking regions may be subjected to mutagenesis.
The regulator DNA sequence of the invention may, if desired, be combined with other DNA sequences in a variety of ways. The regulator DNA sequence of the invention may be employed with all or part of the gene sequences normally associated with itself. In its component parts, a DNA sequence encoding a regulator polypeptide (e.g., a CDPK, a PK domain, or a CaM-K) is combined in a DNA construct having a transcription initiation control region capable of promoting transcription and translation in a host cell. In general, the constructs will involve regulatory regions functional in plants which provide for modified production of the regulator protein as discussed herein. The open reading frame coding for the regulator protein or functional fragment thereof will be joined at its 5' end to a transcription initiation regulatory region such as the sequence naturally found in the 5' upstream region of the regulator structural gene (e.g., CDPK, PK domain, or CaM-K). Numerous other transcription initiation regions are available which provide for constitutive or inducible regulation.
For applications where developmental, cell, tissue, hormonal, or environmental expression is desired, appropriate 5' upstream non-coding regions are obtained from other genes, for example, from genes regulated during meristem development, seed development, embryo development, or leaf
development.
Regulatory transcript termination regions may also be provided in DNA constructs of this invention as well. Transcript termination regions may be provided by the DNA sequence encoding the regulator protein (e.g., CDPK, PK domain, or CaM-K) or any convenient transcription termination region derived from a different gene source. The transcript termination region will contain preferably at least 1-3 kb of sequence 3' to the structural gene from which the termination region is derived. Plant expression constructs having, for example, CDPK as the DNA sequence of interest for expression may be employed with a wide variety of plant life. Such genetically-engineered plants are useful for a variety of industrial and agricultural applications as discussed herein. Importantly, this invention is applicable to dicotyledons and monocotyledons, and will be readily applicable to any new or improved transformation or regeneration method. An example of a useful plant promoter according to the invention is a caulimovirus promoter, for example, a cauliflower mosaic virus (CaMV) promoter. These promoters confer high levels of expression in most plant tissues, and the activity of these promoters is not dependent on virally encoded proteins. CaMV is a source for both the 35S and 19S promoters. In most tissues of transgenic plants, the CaMV 35S promoter is a strong promoter (see, e.g., Odell et al. Nature 313:810, 1985). The CaMV promoter is also highly active in monocots (see, e.g., Dekeyser et al. Plant Cell 2:591, 1990; Terada and Shimamoto, Mol. Gen. Genet. 220:389, 1990). Moreover, activity of this promoter can be further increased (i.e., between 2-10 fold) by duplication of the CaMV 35S promoter (see e.g., Kay et al. Science 236: 1299, 1987; Ow et al, Proc. Natl. Acad. Sci., U.S.A. 84:4870, 1987; and Fang et al. Plant Cell 1 : 141 , 1989).
Other useful plant promoters include, without limitation, the nopaline synthase promoter (An et al. Plant Physiol. 88:547, 1988) and the octopine synthase promoter (Fromm et al. Plant Cell 1 :977, 1989).
For certain applications, it may be desirable to produce the regulator gene product (e.g., CDPK, PK domain, or CaM-K) in an appropriate tissue, at an appropriate level, or at an appropriate developmental time. For this purpose, there are an assortment of gene promoters, each with its own distinct characteristics embodied in its regulatory sequences, shown to be regulated in response to the environment, hormones, and/or developmental cues. These include gene promoters that are responsible for heat-regulated gene expression (see, e.g., Callis et al. Plant Physiol. 88:965, 1988; Takahashi and Komeda, Mol. Gen. Genet. 219:365, 1989; and Takahashi et al, Plant J. 2:751, 1992), light-regulated gene expression (e.g., the pea rbcS-3A described by Kuhlemeier et al. Plant Cell 1 :471 , 1989; the maize rbcS promoter described by Schaffner and Sheen, Plant Cell 3:997, 1991 ; or the cholorphyll a/b-binding protein gene found in pea described by Simpson et al, EMBO J. 4:2723, 1985), hormone- regulated gene expression (for example, the abscisic acid (ABA) responsive sequences from the Em gene of wheat described by Marcotte et al. Plant Cell 1 :969, 1989; the ABA-inducible HVA1 and HVA22, and rd29A promoters described for barley and Arabidopsis by Straub et al. Plant Cell 6:617, 1994, Shen et al. Plant Cell 7:295, 1995; and wound-induced gene expression (for example, of wunl described by Siebertz et al. Plant Cell 1 :961, 1989), organ- specific gene expression (for example, of the tuber-specific storage protein gene described by Roshal et al, EMBO J. 6: 1155, 1987; the 23-kDa zein gene from maize described by Schemthaner et al, EMBO J. 7: 1249, 1988; or the French bean β-phaseolin gene described by Bustos et al. Plant Cell 1 :839, 1989), or pathogen-inducible promoters (for example, PR-1 or β-1,3 glucanase
promoters).
Plant expression vectors may also optionally include RNA processing signals, e.g, introns, which have been shown to be important for efficient RNA synthesis and accumulation (Callis et al. Genes and Dev. 1 : 1183, 1987). The location of the RNA splice sequences can dramatically influence the level of transgene expression in plants. In view of this fact, an intron may be positioned upstream or downstream of a CDPK, Cam-K, or PK domain polypeptide-encoding sequence in the transgene to modulate levels of gene expression. In addition to the aforementioned 5' regulatory control sequences, the expression vectors may also include regulatory control regions which are generally present in the 3' regions of plant genes (Thomburg et al, Proc. Natl. Acad. Sci. U.S.A. 84:744, 1987; An et al. Plant Cell 1 : 115, 1989). For example, the 3' terminator region may be included in the expression vector to increase stability of the mRNA. One such terminator region may be derived from the PI-II teπninator region of potato. In addition, other commonly used terminators are derived from the octopine or nopaline synthase signals.
The plant expression vector also typically contains a dominant selectable marker gene used to identify those cells that have become transformed. Useful selectable genes for plant systems include genes encoding antibiotic resistance genes, for example, those encoding resistance to hygromycin, kanamycin, bleomycin, G418, streptomycin, or spectinomycin. Genes required for photosynthesis may also be used as selectable markers in photosynthetic-deficient strains. Finally, genes encoding herbicide resistance may be used as selectable markers; useful herbicide resistance genes include the bar gene encoding the enzyme phosphinothricin acetyltransferase and conferring resistance to the broad spectrum herbicide Basta® (Hoechst AG,
Frankfurt, Germany).
Efficient use of selectable markers is facilitated by a determination of the susceptibility of a plant cell to a particular selectable agent and a determination of the concentration of this agent which effectively kills most, if not all, of the transformed cells. Some useful concentrations of antibiotics for tobacco transformation include, e.g., 75-100 μg/mL (kanamycin), 20-50 μg/mL (hygromycin), or 5-10 μg/mL (bleomycin). A useful strategy for selection of transformants for herbicide resistance is described, e.g., by Vasil et al, supra.
It should be readily apparent to one skilled in the art of molecular biology, especially in the field of plant molecular biology, that the level of gene expression is dependent, not only on the combination of promoters, RNA processing signals, and terminator elements, but also on how these elements are used to increase the levels of selectable marker gene expression.
Plant Transformation Upon construction of the plant expression vector, several standard methods are available for introduction of the vector into a plant host, thereby generating a transgenic plant. These methods include (1) Agrobacterium- mediated transformation (A. tumefaciens or A. rhizogenes) (see, e.g., Lichtenstein and Fuller, In: Genetic Engineering, vol 6, PWJ Rigby, ed, London, Academic Press, 1987; and Lichtenstein, C.P, and Draper, J,. In: DNA Cloning, Vol II, D.M. Glover, ed, Oxford, IRI Press, 1985)), (2) the particle delivery system (see, e.g., Gordon-Kamm et al. Plant Cell 2:603 (1990); or BioRad Technical Bulletin 1687, supra), (3) microinjection protocols (see, e.g., Green et al, supra), (4) polyethylene glycol (PEG) procedures (see, e.g., Draper et al. Plant Cell Physiol. 23:451, 1982; or e.g., Zhang and Wu, Theor. Appl. Genet. 76:835, 1988), (5) liposome-mediated DNA uptake (see, e.g.,
Freeman et al. Plant Cell Physiol. 25: 1353, 1984), (6) electroporation protocols (see, e.g., Gelvin et al, supra; Dekeyser et al, supra; Fromm et al. Nature 319:791 , 1986; Sheen, Plant Cell 2: 1027, 1990; or Jang and Sheen, Plant Cell 6: 1665, 1994), and (7) the vortexing method (see, e.g., Kindle supra). The method of transformation is not critical to the invention. Any method which provides for efficient transformation may be employed. As newer methods are available to transform crops or other host cells, they may be directly applied. The following is an example outlining one particular technique, an Agrobacterium-mediated plant transformation. By this technique, the general process for manipulating genes to be transferred into the genome of plant cells is carried out in two phases. First, cloning and DNA modification steps are carried out in E. coli, and the plasmid containing the gene construct of interest is transferred by conjugation or electroporation into Agrobacterium. Second, the resulting Agrobacterium strain is used to transform plant cells. Thus, for the generalized plant expression vector, the plasmid contains an origin of replication that allows it to replicate in Agrobacterium and a high copy number origin of replication functional in E. coli. This permits facile production and testing of transgenes in E. coli prior to transfer to Agrobacterium for subsequent introduction into plants. Resistance genes can be carried on the vector, one for selection in bacteria, for example, streptomycin, and another that will function in plants, for example, a gene encoding kanamycin resistance or herbicide resistance. Also present on the vector are restriction endonuclease sites for the addition of one or more transgenes and directional T-DNA border sequences which, when recognized by the transfer functions of Agrobacterium, delimit the DNA region that will be transferred to the plant.
In another example, plant cells may be transformed by shooting into the cell tungsten microprojectiles on which cloned DNA is precipitated. In the
Biolistic Apparatus (Bio-Rad) used for the shooting, a gunpowder charge (22 caliber Power Piston Tool Charge) or an air-driven blast drives a plastic macroprojectile through a gun barrel. An aliquot of a suspension of tungsten particles on which DNA has been precipitated is placed on the front of the plastic macroprojectile. The latter is fired at an acrylic stopping plate that has a hole through it that is too small for the macroprojectile to pass through. As a result, the plastic macroprojectile smashes against the stopping plate, and the tungsten microprojectiles continue toward their target through the hole in the plate. For the instant invention the target can be any plant cell, tissue, seed, or embryo. The DNA introduced into the cell on the microprojectiles becomes integrated into either the nucleus or the chloroplast.
In general, transfer and expression of transgenes in plant cells are now routine practices to those skilled in the art, and have become major tools to carry out gene expression studies in plants and to produce improved plant varieties of agricultural or commercial interest.
Transgenic Plant Regeneration
Plant cells transformed with a plant expression vector can be regenerated, for example, from single cells, callus tissue, or leaf discs according to standard plant tissue culture techniques. It is well known in the art that various cells, tissues, and organs from almost any plant can be successfully cultured to regenerate an entire plant; such techniques are described, e.g., in
Vasil supra; Green et al, supra; Weissbach and Weissbach, supra; and Gelvin et al, supra.
In one particular example, a cloned CDPK polypeptide (or PK domain or CaM-K) construct under the control of the nos promoter and the nopaline synthase terminator and carrying a selectable marker (for example,
kanamycin resistance) is transformed into Agrobacterium. Transformation of leaf discs (for example, of tobacco or potato leaf discs), with vector- containing Agrobacterium is carried out as described by Horsch et al. (Science 227: 1229, 1985). Putative transformants are selected after a few weeks (for example, 3 to 5 weeks) on plant tissue culture media containing kanamycin (e.g. 100 μg/mL). Kanamycin-resistant shoots are then placed on plant tissue culture media without hormones for root initiation. Kanamycin-resistant plants are then selected for greenhouse growth. If desired, seeds from self- fertilized transgenic plants can then be sowed in a soil-less medium and grown in a greenhouse. Kanamycin-resistant progeny are selected by sowing surfaced sterilized seeds on hormone-free kanamycin-containing media. Analysis for the integration of the transgene is accomplished by standard techniques (see, for example, Ausubel et al. supra; Gelvin et al. supra).
Transgenic plants expressing the selectable marker are then screened for transmission of the transgene DNA by standard immunoblot and DNA detection techniques. Each positive transgenic plant and its transgenic progeny are unique in comparison to other transgenic plants established with the same transgene. Integration of the transgene DNA into the plant genomic DNA is in most cases random, and the site of integration can profoundly affect the levels and the tissue and developmental patterns of transgene expression.
Consequently, a number of transgenic lines are usually screened for each transgene to identify and select plants with the most appropriate expression profiles.
Transgenic lines are evaluated for levels of transgene expression. Expression at the RNA level is determined initially to identify and quantitate expression-positive plants. Standard techniques for RNA analysis are employed and include PCR amplification assays using oligonucleotide primers
designed to amplify only transgene RNA templates and solution hybridization assays using transgene-specific probes (see, e.g., Ausubel et al, supra). The RNA-positive plants are then analyzed for protein expression by Western immunoblot analysis using specific antibodies (see, e.g., Ausubel et al, supra). In addition, in situ hybridization and immunocytochemistry according to standard protocols can be done using transgene-specific nucleotide probes and antibodies, respectively, to localize sites of expression within transgenic tissue.
In addition, if desired, once the recombinant regulator protein (e.g., CDPK, PK domain, or CaM-K) is expressed in any cell or in a transgenic plant (for example, as described above), it may be isolated, e.g., using affinity chromatography. In one example, an anti-regulator polypeptide antibody (e.g., produced as described in Ausubel et al, supra, or by any standard technique) may be attached to a column and used to isolate the polypeptide. Lysis and fractionation of regulator-producing cells prior to affinity chromatography may be performed by standard methods (see, e.g., Ausubel et al, supra). Once isolated, the recombinant protein can, if desired, be further purified, for example, by high performance liquid chromatography (see, e.g., Fisher, Laboratory Techniques In Biochemistry And Molecular Biology, eds. Work and Burdon, Elsevier, 1980).
Engineering Stress-Protected Transgenic Plants
As discussed above, plasmid constructs designed for the expression of regulator gene products (e.g., a CDPK, a PK domain, or a CaM-K) are useful for generating transgenic plants having an increased level of tolerance to environmental stress. To achieve such tolerance, it is important to express a regulator gene product at an effective level. Evaluation of the level of stress protection conferred to a plant by expression of regulator gene is determined
according to conventional methods and assays.
In one working example, constitutive expression of the PK domain gene in tomato is used to enhance salt stress tolerance. Specifically, a plant expression vector is constructed that contains a PK cDNA sequence expressed under the control of the nos promoter, a low constitutive promoter. This expression vector is then used to transform tomato according to standard methods. To assess salt tolerance, transformed tomato plants and appropriate controls are evaluated according to methods described in Lilus et al. (BioTechnology 14: 177, 1996) and Tarczynski et al. (Science 259:508, 1993). Transformed tomato plants that express a PK domain gene having an increased level of salt tolerance relative to control plants are taken as being useful in the invention.
Use
The invention described herein is useful for a variety of agricultural and commercial purposes including, but not limited to, improving tolerance to a variety of environmental stresses, including but not limited to, drought, salinity, cold, and heat, increasing crop yields, improving crop and ornamental quality, and reducing agricultural production costs. In particular, expression of a regulator gene (e.g., a CDPK, a PK domain, or a CaM-K gene) in a plant cell provides tolerance to such stress and can be used to protect plants from adverse conditions that reduce plant productivity and viability. The invention therefore affords a means for producing plants that can live in environments where growth would otherwise be impaired by adverse environmental factors.
All publications and patent applications mentioned in this specification are herein incorporated by reference to the same extent as if each
independent publication or patent application was specifically and individually indicated to be incorporated by reference.
What is claimed is:
Claims
1. A method for protecting a plant against an environmental stress,
said method comprising the steps of:
(a) producing a transgenic plant cell comprising a recombinant PK
domain-containing gene integrated into the genome of said transgenic plant cell
and positioned for expression in said transgenic plant cell, said PK domain-
containing gene being capable of increasing the level of tolerance to an
environmental stress; and
(b) growing a transgenic plant from said plant cell, wherein said PK
domain-containing gene is expressed in said transgenic plant.
2. A method for protecting a plant against an environmental stress,
said method comprising the steps of:
(a) producing a transgenic plant cell comprising a recombinant
CDPK gene integrated into the genome of said transgenic plant cell and
positioned for expression in said transgenic plant cell, said CDPK gene being
capable of increasing the level of tolerance to an environmental stress; and
(b) growing a transgenic plant from said plant cell, wherein said
CDPK gene is expressed in said transgenic plant.
3. A method for protecting a plant against an environmental stress,
said method comprising the steps of:
(a) producing a transgenic plant cell comprising a recombinant CaM-
K gene integrated into the genome of said transgenic plant cell and positioned
for expression in said transgenic plant cell; and
(b) growing a transgenic plant from said plant cell, wherein said
CaM-K gene is expressed in said transgenic plant.
4. The method of claim 3, wherein said CaM-K gene comprises a
mammalian CaM-K gene.
5. The method of claim 1 , 2, or 3, wherein said environmental
stress is dehydration, excess salinity, or a temperature stress.
6. The method of claim 1, 2, or 3, wherein said plant is protected
against multiple stress conditions.
7. The method of claim 1, 2, or 3, wherein the expression of said
PK domain-containing gene, said CDPK gene, or said CaM-K gene activates
the expression of a stress-protective protein.
8. The method of claim 1, 2, or 3, wherein said PK domain-
containing gene, said CDPK gene, or said CaM-K gene is constitutively
expressed in said transgenic plant.
9. A method for protecting a plant against an environmental stress,
said method comprising the steps of:
(a) producing a transgenic plant cell comprising a combination of at
least two genes selected from the group consisting of a recombinant PK domain
gene, a recombinant CDPK gene, and a CaM-K gene, each of said genes being
capable of increasing the level of tolerance to an environmental stress, each of
said genes being integrated into the genome of said transgenic plant cell and
positioned for expression in said transgenic plant cell; and
(b) growing a transgenic plant from said plant cell, wherein a
combination of at least two of said genes is expressed in said transgenic plant.
10. A transgenic plant comprising a recombinant PK domain gene
integrated into the genome of the transgenic plant and positioned for expression
in the plant, wherein said PK domain gene is capable of increasing the level of
tolerance, on a plant expressing said PK domain gene, to an environmental
stress.
1 1. A transgenic plant comprising a recombinant CDPK gene
integrated into the genome of the transgenic plant and positioned for expression
in the plant, wherein said CDPK gene is capable of increasing the level of
tolerance, on a plant expressing said CDPK gene, to an environmental stress.
12. A transgenic plant comprising a recombinant CaM-K gene
integrated into the genome of the transgenic plant and positioned for expression
in the plant, wherein said CaM-K gene is capable of increasing the level of
tolerance, on a plant expressing said CaM-K gene, to an environmental stress.
13. A transgenic plant comprising a recombinant CDPK gene, PK
domain gene,
CaM-K gene, or any combination thereof integrated into the genome of the
transgenic plant cell and positioned for expression in said plant cell, wherein
said genes are capable of increasing the level of tolerance to an environmental
stress, on a plant expressing said genes, to an environmental stress.
14. A seed or a cell from a transgenic plant of claim 10, 11, 12, or
13.
15. Substantially pure DNA encoding a PK domain polypeptide,
said polypeptide being capable of increasing the level of tolerance to an
environmental stress in a transgenic plant.
16. The DNA of claim 15, wherein said DNA encodes a
polypeptide which confers tolerance to dehydration, salinity, or a temperature
stress.
17. The DNA of claim 15, wherein said DNA comprises a nucleic
acid sequence substantially identical to the nucleic acid sequence shown in Fig.
5 (SEQ ID NO: 1).
18. The DNA of claim 15 , wherein said DNA is operably linked to
an expression control region, wherein said expression control region comprises
a promoter, wherein said promoter is a constitutive promoter or an inducible
promoter.
19. A cell which includes the DNA of claim 15.
20. The cell of claim 19, wherein said cell is a plant cell.
21. A substantially pure PK domain polypeptide capable of
conferring tolerance to an environmental stress in a transgenic plant.
22. The polypeptide of claim 2, wherein said polypeptide
comprises an amino acid sequence substantially identical to the amino acid
sequence shown in Fig. 5 (SEQ ID NO: 2).
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3296696P | 1996-12-13 | 1996-12-13 | |
US32966P | 1996-12-13 | ||
PCT/US1997/023019 WO1998026045A1 (en) | 1996-12-13 | 1997-12-12 | Stress-protected transgenic plants |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1015556A1 true EP1015556A1 (en) | 2000-07-05 |
EP1015556A4 EP1015556A4 (en) | 2004-05-26 |
Family
ID=21867832
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP97954562A Withdrawn EP1015556A4 (en) | 1996-12-13 | 1997-12-12 | Stress-protected transgenic plants |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1015556A4 (en) |
AU (1) | AU5898298A (en) |
CA (1) | CA2274580A1 (en) |
WO (1) | WO1998026045A1 (en) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6706866B1 (en) | 1996-09-04 | 2004-03-16 | Michigan State University | Plant having altered environmental stress tolerance |
US6262345B1 (en) | 1998-07-10 | 2001-07-17 | E. I. Du Pont De Nemours & Company | Plant protein kinases |
GB9917642D0 (en) * | 1999-07-27 | 1999-09-29 | Zeneca Ltd | Improvements in or relating to organic compounds |
DE60034069T2 (en) * | 1999-12-22 | 2007-12-06 | Basf Plant Science Gmbh | STRESS-COUPLED TRANSCRIPTION FACTOR PROTEINS AND METHODS FOR THEIR USE IN PLANTS |
US7223903B2 (en) | 1999-12-22 | 2007-05-29 | Da Costa E Silva Oswaldo | Protein kinase stress-related proteins and methods of use in plants |
WO2001077161A2 (en) * | 2000-04-07 | 2001-10-18 | Basf Plant Science Gmbh | Gtp binding stress-related proteins and methods of use in plants |
WO2001084911A1 (en) * | 2000-05-05 | 2001-11-15 | The General Hospital Corporation | Calcium dependent protein kinase polypeptides as regulators of plant disease resistance |
US8022272B2 (en) | 2001-07-13 | 2011-09-20 | Sungene Gmbh & Co. Kgaa | Expression cassettes for transgenic expression of nucleic acids |
WO2003040171A2 (en) * | 2001-11-09 | 2003-05-15 | Basf Plant Science Gmbh | Protein kinase stress-related polypeptides and methods of use in plants |
EP1645633B1 (en) | 2004-10-05 | 2011-09-21 | SunGene GmbH | Constitutive expression cassettes for regulation of plant expression |
EP1655364A3 (en) | 2004-11-05 | 2006-08-02 | BASF Plant Science GmbH | Expression cassettes for seed-preferential expression in plants |
EP1662000B1 (en) | 2004-11-25 | 2011-03-30 | SunGene GmbH | Expression cassettes for guard cell-preferential expression in plants |
EP1666599A3 (en) | 2004-12-04 | 2006-07-12 | SunGene GmbH | Expression cassettes for mesophyll- and/or epidermis-preferential expression in plants |
EP1669455B1 (en) | 2004-12-08 | 2009-10-28 | SunGene GmbH | Expression cassettes for vascular tissue-preferential expression in plants |
EP1669456A3 (en) | 2004-12-11 | 2006-07-12 | SunGene GmbH | Expression cassettes for meristem-preferential expression in plants |
EP2186903A3 (en) | 2005-02-09 | 2010-09-08 | BASF Plant Science GmbH | Expression cassettes for regulation of expression in monocotyledonous plants |
EP1856264B1 (en) | 2005-02-26 | 2014-07-23 | BASF Plant Science GmbH | Expression cassettes for seed-preferential expression in plants |
EP2045327B8 (en) | 2005-03-08 | 2012-03-14 | BASF Plant Science GmbH | Expression enhancing intron sequences |
CA2604807C (en) | 2005-04-19 | 2018-06-12 | Basf Plant Science Gmbh | Improved methods controlling gene expression |
CA2606220A1 (en) | 2005-04-19 | 2006-12-21 | Basf Plant Science Gmbh | Starchy-endosperm and/or germinating embryo-specific expression in mono-cotyledonous plants |
AU2006245701B2 (en) | 2005-05-10 | 2011-04-28 | Basf Plant Science Gmbh | Expression cassettes for seed-preferential expression in plants |
EP2436769B1 (en) | 2006-06-07 | 2015-04-01 | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. | Plant expression constructs and methods of utilizing same |
US20110035840A1 (en) | 2007-02-16 | 2011-02-10 | Basf Plant Science Gmbh | Nucleic acid sequences for regulation of embryo-specific expression in monocotyledoneous plants |
CA2766918A1 (en) | 2009-06-30 | 2011-01-06 | Ilan Sela | Introducing dna into plant cells |
WO2011003901A1 (en) | 2009-07-10 | 2011-01-13 | Basf Plant Science Company Gmbh | Expression cassettes for endosperm-specific expression in plants |
AU2010325720A1 (en) | 2009-12-03 | 2012-07-19 | Basf Plant Science Company Gmbh | Expression cassettes for embryo-specific expression in plants |
US20150040268A1 (en) | 2013-04-25 | 2015-02-05 | Morflora Israel Ltd | Methods and compositions for the delivery of nucleic acids to seeds |
CN114644696B (en) * | 2020-12-17 | 2023-03-21 | 中国农业大学 | Protein ZMCPK6 and coding gene and application thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995005731A1 (en) * | 1993-08-24 | 1995-03-02 | Cornell Research Foundation, Inc. | Gene conferring disease resistance to plants |
WO1996038566A1 (en) * | 1995-05-31 | 1996-12-05 | Institut National De La Recherche Agronomique | Nucleic acid fragment coding for an enzyme involved in the abscisic acid (aba) biosynthesis pathway in plants |
-
1997
- 1997-12-12 WO PCT/US1997/023019 patent/WO1998026045A1/en not_active Application Discontinuation
- 1997-12-12 AU AU58982/98A patent/AU5898298A/en not_active Abandoned
- 1997-12-12 CA CA002274580A patent/CA2274580A1/en not_active Abandoned
- 1997-12-12 EP EP97954562A patent/EP1015556A4/en not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995005731A1 (en) * | 1993-08-24 | 1995-03-02 | Cornell Research Foundation, Inc. | Gene conferring disease resistance to plants |
WO1996038566A1 (en) * | 1995-05-31 | 1996-12-05 | Institut National De La Recherche Agronomique | Nucleic acid fragment coding for an enzyme involved in the abscisic acid (aba) biosynthesis pathway in plants |
Non-Patent Citations (7)
Title |
---|
BARTELS ET AL: "Approaches to improve stress tolerance using molecular genetics" PLANT CELL AND ENVIRONMENT, XX, XX, vol. 17, 1994, pages 659-667, XP002094723 ISSN: 0140-7791 * |
BOTELLA JOSE R ET AL: "Calcium-dependent protein kinase gene expression in response to physical and chemical stimuli in mungbean (Vigna radiata)" PLANT MOLECULAR BIOLOGY, vol. 30, no. 6, 1996, pages 1129-1137, XP001161149 ISSN: 0167-4412 * |
HONG YAN ET AL: "Expression of three members of the calcium-dependent protein kinase gene family in Arabidopsis thaliana" PLANT MOLECULAR BIOLOGY, NIJHOFF PUBLISHERS, DORDRECHT, NL, vol. 30, no. 6, 1996, pages 1259-1275, XP002158871 ISSN: 0167-4412 * |
HRABAK ESTELLE M ET AL: "Characterization of eight new members of the calmodulin-like domain protein kinase gene family from Arabidopsis thaliana" PLANT MOLECULAR BIOLOGY, vol. 31, no. 2, 1996, pages 405-412, XP001161139 ISSN: 0167-4412 * |
See also references of WO9826045A1 * |
SHEEN J: "CA2+-DEPENDENT PROTEIN KINASES AND STRESS SIGNAL TRANSDUCTION IN PLANTS" SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, US, vol. 274, no. 5294, 13 December 1996 (1996-12-13), pages 1900-1902, XP001018973 ISSN: 0036-8075 * |
URAO TAKESHI ET AL: "Two genes that encode Ca-2+ -dependent protein kinases are induced by drought and high-salt stresses in Arabidopsis thaliana" MOLECULAR AND GENERAL GENETICS, SPRINGER VERLAG, BERLIN, DE, vol. 244, no. 4, 1994, pages 331-340, XP002158872 ISSN: 0026-8925 * |
Also Published As
Publication number | Publication date |
---|---|
AU5898298A (en) | 1998-07-03 |
CA2274580A1 (en) | 1998-06-18 |
WO1998026045A1 (en) | 1998-06-18 |
EP1015556A4 (en) | 2004-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1015556A1 (en) | Stress-protected transgenic plants | |
EP1590447B1 (en) | Stem-regulated, plant defense promoter and uses thereof in tissue-specific expression in monocots | |
US20060185030A1 (en) | Cytokinin response regulators and uses thereof | |
US5859346A (en) | Crucifer AFT proteins and uses thereof | |
US7973217B2 (en) | Stem-regulated, plant defense promoter and uses thereof in tissue-specific expression in monocots | |
US6613959B1 (en) | Transgenic plants expressing a MAPKKK protein kinase domain | |
AU715535B2 (en) | Plant glutathione S-transferase promoters | |
US6639130B2 (en) | Plant sterol reductases and uses thereof | |
WO1997048793A9 (en) | Plant sterol reductases and uses thereof | |
AU722002B2 (en) | Plant sugar sensors and uses thereof | |
US7084323B1 (en) | Stress-protected transgenic plants | |
US6548743B1 (en) | Transgenic plants expressing a dual-specificity MAPK phosphatase and uses thereof | |
WO2001084911A1 (en) | Calcium dependent protein kinase polypeptides as regulators of plant disease resistance | |
US20030219763A1 (en) | Plant protoplast gene expression systems and uses thereof | |
WO2001068920A1 (en) | Plant protoplast gene expression systems and uses thereof | |
AU758678B2 (en) | Plant sugar sensors and uses thereof | |
US6841722B1 (en) | Nucleic acid encoding the arabidopsis SSE1 protein and a method of using it to modify plant storage reserves | |
WO2000012713A1 (en) | Plant promoter sequence and uses therefor | |
WO2000061735A1 (en) | Modification of plant storage reserves |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19990712 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): BE DE ES FR GB |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20040416 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: 7A 01H 5/00 B Ipc: 7C 12N 9/12 B Ipc: 7C 12N 15/82 A |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20050701 |